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Canonical non-homologous end joining (C-NHEJ), a major DNA double-strand break 
(DSB) repair pathway, is required for the repair of general DSBs as well as programmed breaks 
generated during antigen receptor gene rearrangements by V(D)J recombination.  During this 
process, the lymphocyte-specific RAG1/2 endonuclease generates DSBs at numerous V, D and J 
genomic segments. The DNA ends are maintained in a postcleavage complex to facilitate end 
joining by C-NHEJ proteins, including Artemis, a DNA nuclease. Proper end joining is essential 
for lymphocyte development, immune diversification and to suppress structural chromosomal 
aberrations. Patients with null and hypomorphic mutations in RAG, Artemis and other C-NHEJ 
genes develop immunodeficiency disorders.  Hypomorphic Artemis mutations that result in loss 
of the C-terminus are also associated with lymphomas harboring chromosomal translocations 
at the antigen receptor loci. The mechanisms that promote genomic instability in these patients 
are not entirely clear. This dissertation is focused on elucidating the roles of RAG1 and Artemis 
in preventing genomic instability during V(D)J recombination. These studies provide the first in 
vivo evidence that hypomorphic Rag1 and Artemis mutations result in unique molecular defects 
characterized by chromosomal translocations at the RAG-induced breaks in non-malignant cells. 
My findings suggest that RAG1 and Artemis play important roles in maintaining postcleavage 
complex stability. Disruption of these complexes in the hypomorphic mutant lymphocytes 
results in premature release of DNA ends that may engage in aberrant V(D)J recombination. 
Recurrent chromosomal translocations are also a hallmark of sporadic human hematological 
malignancies, and of progenitor-B cell lymphomas in mice with combined C-NHEJ and tumor 
suppressor p53 deficiencies. Distinct alternative end joining (A-EJ) mechanisms have been 
implicated in mediating these translocations. The mechanisms that activate A-EJ are poorly 
characterized. My studies have demonstrated that induction of DNA damage response triggers 
alternative end-joining (A-EJ) in lymphocytes in the absence of Artemis resulting in 
chromosomal translocations at RAG-induced breaks. In summary, I have identified novel 
functions for RAG and Artemis in maintaining chromosomal integrity during V(D)J 
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recombination. These studies have improved our understanding of the origin of potentially 
oncogenic chromosomal translocations and have important clinical implications for both 










Mechanism and Regulation of V(D)J Recombination 
 
1.1 Overview 
The work presented in this thesis is focused on examining the functions of RAG1 and 
Artemis in maintaining genomic stability during V(D)J recombination. Chapter 1 offers an 
introduction to the process of V(D)J recombination and how it is regulated. I also discuss the 
mechanisms that lead to aberrant V(D)J recombination and genomic instability. Chapter 2 
includes parts of two published studies that investigated the roles of RAG1 and Artemis in 
maintaining postcleavage complex stability during V(D)J recombination in mice. Chapter 3 is a 
manuscript in preparation. This study explores the role of ATM-dependent DNA damage 
response in inducing end joining in Artemis-deficient mouse lymphocytes. In the last chapter, I 
summarize my conclusions and discuss potential future directions and implications of these 
studies. 
1.2 Abstract 
V(D)J recombination is a series of lymphocyte-specific programmed genomic 
rearrangements essential for antigen receptor diversity and lymphocyte development. It is 
initiated by the generation of DNA double strand breaks by RAG1/2 endonuclease at the 
germline V, D and J segments generating hairpin sealed coding ends. The DNA ends are 
subsequently joined by canonical non-homologous end-joining (C-NHEJ), a major double strand 
break repair pathway. During end-joining, the hairpin intermediates are opened by DNA-PKcs-
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dependent Artemis endonuclease activity, and then joined by DNA Ligase IV/XRCC4 with 
junctional modifications. Defective V(D)J recombination due to mutations in cleavage or end-
joining factors results in impaired lymphocyte development and immunodeficiency. Proper end 
joining is also essential to maintain genomic integrity during this process. Hypomorphic Artemis 
and DNA Ligase IV mutations predispose to lymphomagenesis in patients, though the 
underlying mechanisms are not clear. Likewise, mutations in other DNA damage response 
factors result in lymphomas bearing chromosomal translocations at the antigen receptor loci in 
both patients and mice. Clonal oncogenic translocations involving the RAG-induced breaks are 
also a hallmark of sporadic human hematological malignancies.  These rearrangements are 
mediated by distinct, but poorly understood, alternative end joining (A-EJ) mechanism(s). Error-
prone A-EJ is also actively involved in IgH and c-myc/N-myc genes rearrangements observed in 
progenitor-B cell lymphomas in mice with combined C-NHEJ and p53 deficiencies.  In this 
chapter, I discuss the functions of RAG1/2 and Artemis proteins in the regulation of V(D)J 
recombination, disorders associated with aberrant cleavage and end joining, the role of DNA 
damage response during this process, and how defects in these processes contribute to 
genomic instability and lymphomagenesis.  
1.3 Introduction To V(D)J Recombination 
The adaptive immune system in the jawed vertebrates (cartilaginous fishes to 
mammals) is characterized by a vastly diverse repertoire of antigen receptors known as the T 
cell receptors (TCR) and B cell receptors (BCR) or immunoglobulins (Ig) expressed on the T and B 
lymphocyte cell surfaces, respectively [1]. Each lymphocyte expresses several receptors of a 
single specificity. A TCR is a heterodimer consisting of either gamma/delta- (γδ), or alpha/beta- 
(αβ) chains. A BCR (or Ig) comprises of two identical heavy (IgH) and two identical light (IgL) 
chains (Figure 1.1, bottom panel). Each antigen receptor comprises of an N-terminus variable 
and a C-terminus constant region. The variable region is formed by about 100 to 120 amino 
acids and is important for antigen recognition and binding [1]. This highly polymorphic region is 
encoded by an exon that is assembled from an array of germline variable (V), diversity (D) and 
joining (J) segments in the developing lymphocytes through a series of DNA rearrangements 
collectively known as V(D)J recombination (Figure 1.1, top panel; Table 1.1) [2]. This complex 
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process is restricted to G1 phase of the cell cycle and can be broadly divided into two phases, 
the cleavage phase and the joining phase [3]. 
 
Figure 1.1: Genomic Rearrangements By V(D)J Recombination and Antigen Receptors 
 
 






V(D)J recombination is initiated by generation of site-specific DNA double strand breaks 
(DSBs) by a highly sophisticated, lymphocyte-restricted recombinase comprising of 
recombination activating gene products, RAG1 and RAG2, herein referred to as RAG1/2 (Figure 
1.2) [4, 5]. Within accessible chromatin, RAG1/2 recombinase recognizes recombination signal 
sequences (RSSs) that flank individual V, D and J gene segments. Each RSS comprises of 
conserved heptamer and nonamer sequences (5’-CACAGTG-3’ and 5’-ACAAAAACC-3’, 
respectively) separated by a non-conserved spacer of either 12 or 23 nucleotides in length [6]. 
RSS-RAG1/2 interaction forms a signal complex which then captures a second appropriate RSS 
bringing two distant segments together in a stable synaptic or paired complex (capture model) 
(Figure 1.2) [7]. These two segments can be less than 20 kb to more than 100 kb apart. 
Recombination has a strong preference for 12/23 synapsis (based on spacer length) occurring 
only between two gene segments that are flanked by 12-RSS and 23-RSS to ensure ordered 
assembly of rearranging segments. Coupled cleavage within the two segments is initiated when 
RAG1/2 nicks at the 5’ end of the heptamer (heptamer-coding sequence junction) resulting in 
3’-OH which is used to catalyze a transesterification reaction on the opposite phosphodiester 
bond [8]. This generates four recombination intermediates, two covalently sealed hairpin 
coding ends and two 5’ phosphorylated blunt signal ends [9, 10]. These DNA ends are held 
together by RAG proteins in a postcleavage complex (PCC) that protects the ends from 








Figure 1.2: RAG-Mediated Cleavage and DNA End Complex Assembly 
 
 
Joining phase- Role of Canonical Non-homologous End-Joining (C-NHEJ) Factors. 
RAG-induced breaks are joined by the ubiquitously expressed canonical non-homologous end-
joining (C-NHEJ) proteins including DNA-PK complex (comprising of Ku70/80 heterodimer and 
DNA-dependent protein kinase catalytic subunit, DNA-PKcs), Artemis, XRCC4, DNA ligase IV 
(LigIV) and XRCC4-like factor (XLF or Cernunnos) (Figure 1.3) [12-15]. The DNA ends are 
recognized and held together by Ku70/80 heterodimer which recruits DNA-PKcs [16]. 
Interaction with Ku and the DNA ends activates DNA-Pkcs kinase leading to 
autophosphorylation in trans as well as phosphorylation of Artemis [15, 17]. In complex with 
DNA-PKcs, Artemis acquires endonuclease activity which is required to open the hairpins at the 
coding ends [15]. An overhang at the coding end containing an inverted repeat, the palindromic 
(P) nucleotides, may result from asymmetrical hairpin opening 1 or 2 nucleotides away from the 
apex [18]. The coding junctions may be further diversified through exonuclease-mediated 
deletions. Nucleotides may also be added by template-dependent DNA polymerases (Pol µ/λ) 
or randomly (N nucleotides) by lymphocyte-specific template-independent Terminal 
deoxynucleotidyl Transferase (TdT) [19, 20].  The N nucleotides are usually GC-rich. The 
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modified ends are joined by DNA LigIV/XRCC4 to form a coding join or V(D)J exon [21]. Only one 
third of the exons formed by this process are in-frame and productive. The RSS ends are directly 
joined without any processing to form a precise signal joint. DNA-PKcs and Artemis are essential 
for only coding, and not signal, join formation [22, 23]. A detailed discussion of all the factors 
involved in V(D)J recombination is beyond the scope of this thesis. Since my thesis work is 
focused on RAG and Artemis, the structure and functions of these proteins will be discussed in 
detail in sections 1.3 and 1.4. 
Figure 1.3: Cleavage and Joining Phases of V(D)J Recombination 
 




1.4 Structure and Functions of RAG1/2 Complex 
The origin of RAG genes and Recombination Signal Sequences (RSS).  
The functions of lymphocyte-specific TdT and RAG recombinase in V(D)J recombination were 
established about 500 million years ago between the divergence of the jawless and 
cartilaginous fishes, a span of almost 80 million years [24-26]. Several genetic and biochemical 
studies on the origin of V(D)J recombination suggest that sequences within the RAG1 gene and 
RSSs were derived from transposons [27-29]. In 1979, Sakano et al. observed sequence 
similarities between RSSs and signal motifs at the termini of the integrated transposable 
elements [27]. Transib transposons in the genomes of nematodes, insects and sea urchin also 
contain RSS-like genetic elements [29]. Genomic sequences of unknown significance, similar to 
RAG1 and RAG2 genes have been discovered in sea urchin [30]. Additionally, RAG1 contains 
catalytic motif found in many integrases and transposases including the Transib transposases. 
Functional studies suggest that mechanism of DNA cleavage by direct transesterification is 
common between these enzymes [31, 32]. RAG complex has also been shown to be capable of 
functioning as a transposase in vitro and rarely in vivo [33-37]. These studies provide strong 
evidence that RAG1 and Transib transposases have a common progenitor.  
RAG1 and RAG2 domain organization and functions. 
The RAG1 and RAG2 genes are both located on human chromosome 11p13 and mouse 
chromosome 2p [5](www.ncbi.nlm.nih.gov/). Murine RAG1 and RAG2 proteins contain 1040 
and 527 amino acids, respectively. Only core RAG1 (384-1008aa) and core RAG2 (1-387aa) are 
required for recombination reaction in cell-free assays [8]. The non-core regions have been 
suggested to contain regulatory functions [38]. Mutagenesis and structural analyses have 
provided useful clues regarding their functions.  
Core RAG1 contains (1) a nonamer binding domain (NBD) (aa 389-442), (2) a central domain (aa 
528-760) and (3) a C-terminal domain (CTD) (aa761-979) (Figure 1.4, top panel) [39-41]. NBD, as 
the name indicates, binds the nonamer sequence within the RSS [42]. The central domain 
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interacts with RAG2, binds the heptamer sequence and single-stranded DNA. The CTD non-
specifically binds double-stranded DNA. It also mediates interaction with the coding sequence 
adjacent to the RSS [43]. The central domain and CTD contain the catalytic DDE motif (asp-600, 
asp-708 and glu-962) [31, 44]. The distal non-core part of C-terminus (aa1009-1040) regulates 
RAG binding and cleavage activities by collaborating with RAG2 C-terminus. The non-core N 
terminal region plays roles in regulating protein levels, interaction with other proteins, 
coordination of zinc ions, and enhancing V(D)J recombination activity [43]. It also contains zinc-
binding dimerization domain (aa 265-380).  
RAG2 protein consists of (1) core RAG2 (aa 1-387) containing 6 kelch-like motifs (aa 1-350), (2) a 
flexible acidic hinge region (aa 360-408), and (3) C-terminal non-canonical plant homeodomain 
(PHD) (aa 414-487) (Figure 1.4, bottom panel) [40, 43]. Kelch like motifs are important for 
RAG1-RAG2 interaction and cleavage [45]. The PHD binds H3K4me3 (histone H3 trimethylated 
at lysine 4) and phosphoinositides. The C-terminus is also required to discriminate between the 
correct and off-target cleavage sites independent of its interaction with H3K4me3 [46]. A 
conserved threonine residue (T490) in the distal C-terminus mediates cell-cycle regulated 
degradation of RAG2 [43].   




RAG1/2 interaction with accessible chromatin.  
RAG1/2 plays important roles in regulating V(D)J recombination which exhibits remarkable 
tissue-, lineage-, development stage- and locus-specificity as well as allelic exclusion. This 
somatic recombination occurs only in lymphoid cells with Ig loci rearranging only in B-lineage 
cells and TCR loci in T-lineage cells. Moreover, recombination is restricted to certain 
development stages, as discussed in detail in section 1.6. The locus specificity is also temporally 
regulated with D-J rearrangements occurring prior to V-DJ. In addition, productive 
rearrangement of one allele prevents rearrangement at another allele via allelic exclusion at 
TCRβ, IgH and IgL loci [47]. It is very tempting to postulate that all these regulatory functions 
are mediated by accessibility to antigen receptor loci in a spatial and temporal manner. Indeed, 
over the last few years, several studies have offered insight into epigenetic modifications 
associated with V(D)J recombination linking regulatory RAG functions to specific alterations in 
chromatin architecture.  
Studies using ChIP analysis have shown enrichment of H3K4me3 at genomic regions undergoing 
V(D)J recombination which also correlates with tissue, lineage and development stage-
specificity [7]. For example, H3K4me3 deposition at antigen receptor loci was not observed in 
fibroblasts.  Also, its enrichment at IgH locus was only observed in pro-B cells, and at TCRβ locus 
in pro-T cells. H3K4me3 marks the transcription start sites of protein-coding genes in the 
genomes of non-malignant cells [48].  RAG2 PHD domain has recently been shown to recognize 
H3K4me3 in a high-resolution crystal structure analysis. Reduced H3K4me3 retention impairs 
V(D)J recombination. Similarly, abrogation of PHD-H3K4me3 interaction severely reduce V(D)J 
recombination in vivo. However, additional factors must be involved to specifically target RAG 
proteins to antigen receptor loci since H3K4me3 is present at many other genomic regions. In 
this context, sequence-specific targeting to RSSs and additional chromatin modifications 
together might ensure RAG targeting to these loci [49]. High mobility group box proteins 
(HMGB1/2)- the DNA-binding and bending proteins- have also been shown to enhance affinity 
of RAG1 for 23RSS in vitro [50, 51]. The in vivo significance of HMGB1/2 proteins in V(D)J 
recombination is yet to be established [52]. In summary, several factors govern RAG binding to 
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DNA including sequence specificity, accessibility within the chromatin and proteins interacting 
with RAG [53].  
Enhancers, promoters and transcription regulate RAG binding to DNA 
Transcription occurs concomitantly with V(D)J recombination at an antigen receptor locus 
suggesting a coordination between the two processes [54]. Both cis- and trans-acting elements 
mediate chromatin modifications that are essential for locus accessibility during V(D)J 
recombination [55]. Loss of cis elements and certain transcription factors is associated with loss 
of both transcription and V(D)J recombination at these loci [56]. Additionally, transcription 
elongation itself regulates recombination [55]. It is not known if the transcription machinery 
interacts directly with RAG recombinase and mechanisms of transcription-recombination 
coupling need to be further investigated.  
Overview of complex assembly and coupled cleavage by RAG 
Quite a few biochemical studies have provided useful insight into the mechanisms of signal and 
paired complex assembly and coupled RSS cleavage by RAG1/2. Here, I give a brief overview of 
the mechanisms involved in complex assembly and cleavage. 
RAG1/2 is necessary and sufficient for cleavage at RSS-coding end [41, 57]. Most of the residues 
responsible for DNA binding and cleavage are found in RAG1 [58]. RAG2 itself has no DNA-
binding activity but enhances RAG1 interaction with the heptamer and specificity of this 
interaction [39, 40]. It is also an important co-factor for the cleavage activity [7]. Several studies 
report that synaptic and paired complexes (SC, PC) contain a RAG1 dimer with two RAG2 
molecules within each complex [7, 59-61]. Other biochemical studies report contradictory 
findings regarding the stoichiometry of RAG1/RAG2 in the SC and PC and this needs to be 
further characterized [62, 63]. Some studies suggest that RAG1/2 interacts with 23-RSS first in a 
SC and then captures a 12-RSS. Others reports show that the order of interaction is 
independent of the spacer length [41]. The mechanisms underlying 12/23 synapsis are also not 
entirely clear. Not all 12/23 pairs exhibit the same recombination efficiency, indicating that 
factors beyond 12/23 pair also restrict cleavage [64]. The three residues within the DDE motif of 
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RAG1 together contribute to a single catalytic site which mediates nicking and hairpin 
formation in trans [41, 44]. After cleavage, the four newly generated ends are held together in a 
post-cleavage complex, the signal ends more stably so than the coding ends [35].  
RAG1/2 channels DNA ends to C-NHEJ. 
DNA DSBs generated during V(D)J recombination (referred to as RAG breaks in this thesis) are 
primarily repaired via C-NHEJ. It is still unclear how the ends are specifically directed to the C-
NHEJ machinery. Deriano et al. recently showed that lack of RAG2 C-terminus in mice allows the 
ends to be repaired by error-prone alternative mechanisms of end-joining even in the presence 
of intact C-NHEJ  [65]. This suggests a key role of RAG2 in maintaining post-cleavage complex 
stability or interaction with C-NHEJ factors and channeling the ends to the proper repair 
pathway.   
Cell cycle-dependent RAG2 degradation 
A conserved threonine residue (T490) in the distal C-terminus of RAG2 mediates cell-cycle 
regulated degradation of RAG2 via ubiquitination [66]. On G1 to S transition, this residue is 
phosphorylated by cyclinA/Cdk2 which allows RAG2 polyubiquitylation followed by 
proteasomal degradation. This is important to restrict V(D)J recombination to G1 phase and to 
prevent propagation of breaks to G2.  Indeed, a RAG2 mutant, p.Thr490Ala, that interferes with 
its degradation allows for homologous recombination-mediated aberrant recombination. 
1.5 Structure and Functions of Artemis 
The Artemis gene is located on the short arm of chromosome 10 in humans and on 
chromosome 2 in mice (www.ncbi.nlm.nih.gov/). Murine Artemis is 705 amino acids long. 
Mouse and human cDNAs share 73% sequence identity and 81% sequence similarity. It is a 
ubiquitously expressed nuclear protein that plays an essential role in V(D)J recombination. 
Artemis is also important for general DNA double strand break repair via C-NHEJ. It is a member 
of the metallo β−lactamase superfamily based on sequence similarities and the predicted 




The highly conserved N-terminus contains β-lactamase and β-CASP domains (Figure 1.5) [18, 
67, 68]. These two domains together constitute the catalytic core of Artemis specific for nucleic 
acids [68]. A histidine residue (his-254) within the β-CASP domain has been reported to be 
critical for full Artemis catalytic activity in vitro [69, 70]. The C-terminus regulatory domain, is 
encoded by a single exon 14 [68]. It occupies almost half the protein, is less conserved and its 
significance is not entirely clear. This region is dispensable for catalytic activity during V(D)J 
recombination on plasmid substrates [68]. It contains at least 14 phosphorylation sites for 
phosphatidylinositol 3-kinase like kinases (PIKKs) including DNA-PKcs and Ataxia-Telangiectasia 
Mutated (ATM) (Figure 1.5) [71, 72] as indicated by the presence of S/T-Q motifs (serine or 
threonine followed by glutamine) [73]. L401 and R402 residues are important for Artemis 
recruitment to the DNA ends by DNA-PKcs (Figure 1.5) [74, 75]. Recent biochemical and 
structural studies have shown that the Artemis C-terminus also directly binds the DNA-binding 
domain (DBD) of DNA LigIV at three critical regions, W489, F492, F493 (Figure 1.5)  [76-78].  
Figure 1.5: Domain Architecture of Artemis  
 
Artemis substrates 
Artemis, in complex with DNA-PKcs, acquires structure-specific endonuclease activity for single-
stranded to double-stranded DNA (ssDNA-dsDNA) transitions including 3’ and 5’ overhangs, and 
hairpin structures, generating blunt or 3’ overhangs [15]. In addition, Artemis/DNA-PKcs 
complex also has endonucleolytic activities on flaps, stem-loops, heterologous loops and gaps 
[79]. This versatility is important in the removal of secondary structures during DNA repair by 
NEHJ.    
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Regulation of Artemis endonucleolytic activity 
The endonuclease activity of Artemis-DNA-PKcs complex is required to open the hairpin 
intermediates generated during V(D)J recombination [80]. Artemis is also important in repair of 
a subset of complex DSBs induced by ionizing radiation [81]. Artemis C-terminus plays 
important roles in regulating its endonuclease activity. Expression of N terminus alone is not 
sufficient to rescue radiosensitivity in Artemis-null cells suggesting that C-terminus has 
important roles in DNA repair [73]. Interaction of Artemis with DNA-PKcs results in its 
recruitment to the DNA ends [74, 75]. Artemis phosphorylation by DNA-PKcs is not necessary 
for activation of its endonucleolytic activity [17, 71]. A mutant Artemis protein that lacks 
majority of phosphorylation sites but retains its interaction with DNA-PKcs exhibits significant 
endonucleolytic activity in a mouse model generated in our lab [82]. Instead, DNA-PKcs 
autophosphorylation at T2609-T2647 cluster enhances Artemis endonucleotlytic activity [17, 
83]. It has been suggested that the conformational change induced in Artemis by the activated 
DNA-PKcs allows it to acquire endonucleolytic activity.  
1.6 Antigen Receptor Loci Assembly 
B and T lymphocytes contain seven antigen receptor loci; IgH, IgLκ, IgLλ and TCRα, β, γ, δ (Table 
1.1). At IgH, TCRβ and TCRδ loci, DJ rearrangement is followed by V to DJ recombination. At IgL, 
TCRα and TCRγ loci, V to J rearrangements occur directly.  
Recombination occurs by deletion or inversion depending on the relative orientation of the 
RSSs. Deletional rearrangement occurs when RSSs are in the opposite orientation and results in 
the retention of the coding join in the chromosome and deletion of the circular chromosome 
containing the signal join (Figure 1.2). When the RSSs are in the same orientation (within Igκ, 
TCRδ and TCRβV14 loci), the intervening genomic region is inverted to form a coding join with 
retention of both joins in the chromosome (Figure 1.6) [84]. Non-functional recombination can 
occur rarely when a coding end joins a signal end (1) in the original configuration (open-and-
shut join) [41, 85, 86] or (2) from the other segment (hybrid join) (Figure 1.2) [41, 85, 86].  Since 
most of this thesis work is focused on examining TCRβ locus rearrangements, I will be 
discussing this in detail here. Recombination at other loci follows the same pattern. 
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Figure 1.6: Inversional Rearrangement 
 
TCRβ locus comprises of 35 V segments; 22 functional and 13 pseudogenes. All but one 
functional segment are located in the 5’ region followed by two clusters of D-J-C (C=constant) 
segments (Figure 1.7) [87]. Vβ14 is located 3’ to D-J-C clusters in the opposite transcriptional 
direction with an enhancer lying between Vβ14 and Cβ2. Rearrangements between 5’ V and DJ 
segments occur by deletion whereas rearrangements between Vβ14 and DJ clusters occur via 
inversion. After rearrangement, promoter region upstream of V region, now closer to enhancer, 
regulates rearranged gene transcription. During mRNA processing, V(D)J exon is spliced 
together with the C exon to be translated in to TCRβ chain.  
 




1.7 Coordination Between V(D)J Rearrangements and Lymphocyte Development 
The regulation of V(D)J recombination in a cell lineage- and stage-specific manner is evident by 
its coordination with lymphocyte development [88].  
T cell development. 
After early precursor cells move to thymus from bone marrow, they go through several stages 
of development which can be broadly classified in to three stages based on the expression of 
CD4 and CD8 cell surface receptors: CD4-CD8- (double negative, DN), CD4+CD8+ (double 
positive, DP) and CD4+ or CD8+ (single positive, SP) cell stages. DN cells are further divided in to 
four stages, DN1, DN2, DN3 and DN4, based on CD44 and CD25 expression (Figure 1.8) [89]. 
TCRβ, γ and δ rearrangements occur in DN cells. TCRγ and δ, which are expressed in γδ-T cells, 
have been suggested to rearrange in DN1/2 stage [90]. However, rearrangement of these two 
loci does not affect progression to the next stage. TCR Dβ-to-Jβ rearrangements occur in DN2 
cells followed by Vβ-to-DJ rearrangements mostly in DN3 stage. The rearranged TCRβ chain, 
along with pre-Tα and CD3 forms pre-TCR. Pre-TCR signaling decreases CD25 and RAG 
expression resulting in DN4 cells committed to αβ T cell lineage. Cells that have successfully 
rearranged TCRβ now go through β-selection with a proliferative burst, accompanied by up-
regulation of CD4 and CD8 resulting in DP cells. TCRα rearrangements occur at this stage that 
leads to the formation of αβ TCR heterodimer (αβ-T cells). DP cells undergo positive selection 
(cells that only react to foreign antigens and not to self antigens) and differentiate in to CD4+ or 
CD8+ SP cells which can eventually populate the peripheral lymphoid organs such as spleen and 




Figure 1.8: Coordination Between T Lymphocyte Development and V(D)J Recombination 
 
 
B cell development. 
 DH to JH rearrangements within the IgH locus start in early and common lymphoid progenitors 
(ELP/CLP) before B lineage specification. VH to DJH rearrangement is completed during B 
lymphocyte development in B220+CD43+ pro B cells, [91, 92] followed by the generation of 
B220+CD43- pre B cells. IgH, together with surrogate light chains λ5 and Vpre-B, is expressed as 
pre-BCR. This triggers signaling for cell proliferation, selecting cells with functional IgH [93]. 
Light chain locus rearrangement occurs subsequently in the pre-B cells. There are two light 
chain isotypes in mammals; kappa (Igκ) and lambda (Igλ) light chains. Igκ is rearranged before 
Igλ. In each cell, IgH and IgL proteins are expressed from only one rearranged corresponding 
allele (allelic exclusion)  and IgL protein comprises of either Igκ or Igλ isotype (isotype 
exclusion). Successful light chain rearrangement results in transition to premature IgM+ B cells.  
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Figure 1.9: Coordination Between B Lymphocyte Development and V(D)J Recombination 
 
 
1.8 DNA Damage Response (DDR) and Mechanisms of End-joining 
DNA DSBs arise as necessary intermediates during meiosis, V(D)J recombination and class 
switch recombination (CSR). CSR is a B lymphocyte-specific process important for 
immunoglobulin isotype switching. In addition, genotoxic DSBs result from ionizing radiation 
(IR), chemotherapeutic drugs, replication across a nick and oxidative free radicals. These breaks 
are detected by MRN complex comprising of MRE11/RAD50/NBS1. The MRN complex tethers 
DNA ends together keeping them in close proximity [94, 95] and activates PIK serine/threonine 
protein kinases which include Ataxia-Telangiectasia Mutated (ATM), DNA-PKcs and ATM- and 
Rad3-Related (ATR) [96]. These kinases, in turn, phosphorylate effector proteins. ATM and DNA-
PKcs can be activated at any stage of cell cycle. However, ATR is primarily activated in post-
replication phase and will not be discussed here.  
Cell cycle checkpoints are important phosphorylation targets that arrest the cell cycle in 
response to DNA damage to allow for DNA repair. There are two major DSB repair pathways: 
homologous recombination (HR) and C-NHEJ. HR requires a homologous sequence on a sister 
chromatid and is active only after DNA replication [97]. C-NHEJ involves direct ligation of ends 
and is active throughout the cell cycle. My studies are focused on the NHEJ pathway for DSB 
repair. If DNA repair fails, cells undergo senescence or apoptosis. Rarely, DSBs are misrepaired 
leading to structural chromosomal aberrations like deletions, inversions and translocations 
which can be potentially oncogenic.  Here, I will discuss aspects of DNA damage response 
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relevant to this thesis work. This includes the role of ATM kinase and end-joining mechanisms 
particularly during V(D)J recombination. 
Ataxia Telangiectasia Mutated (ATM). 
ATM kinase exists as an inactive homodimer [98]. In response to DSBs, it is recruited to the site 
of damage through direct interaction with NBS1, a member of the MRN complex [98]. At the 
site of damage, it undergoes autophosphorylation at serine 1981 forming active monomers and 
in turn regulates numerous processes that include cell cycle checkpoint activation, DNA repair, 
apoptosis and gene transcription [99, 100]. Some of its important phosphorylation targets are 
checkpoint kinase Chk2, H2 histone variant H2AX, tumor suppressor p53, MRE11 and NBS1 
[101-103]. H2AX is phorphorylated at Serine 139 (γH2AX) by ATM, ATR and DNA-PKcs on DNA 
damage [104]. This helps in recruiting other DDR proteins or retaining them at the site of 
damage. p53-mediated apoptosis is important to remove cells with unrepaired breaks. ATM 
mutations are associated with genomic instability disorders discussed in detail in sections 1.9 
and 1.10. 
C-NHEJ during general DNA DSB repair: 
During general DSB repair, NHEJ factors repair the ends with minimal end modifications to 
preserve genetic information. About 90% of the DSBs are repaired by NHEJ [105].The core C-
NHEJ factors- Ku70, Ku80, Ligase IV and XRCC4- are conserved from yeast to mammals and 
sufficient to join compatible DNA DSBs [106]. Radiation-induced breaks, that often contain 
complex nucleotide damage, require processing by nucleases and/or gap-filling synthesis by 
polymerases to be joined [107]. Artemis and DNA polymerases µ/λ are required to repair this 
subset of DSBs. Another factor, XLF, enhances the ligation activity on the non-compatible ends 
in vitro [14] and gap-filling by polymerases [108]. The process of end-joining during DSB repair 
proceeds as described for V(D)J recombination in section 1.2. 
Alternative non-homologous end-joining pathway(s) (A-NHEJ). 
End-joining that occurs in the absence of C-NHEJ and is not reliant on long stretches of 
homology is broadly defined as alternative end-joining [106]. However, it may involve one or 
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more distinct pathways [64, 83, 109]. It appears to be kinetically slower than C-NHEJ [110-113]. 
Previously, microhomology-mediated end-joining (MMEJ) was considered to be responsible for 
all A-NHEJ. More recently, it has been suggested that this is not an absolute requirement 
although the use of terminal microhomology may be increased in A-NHEJ [64, 83, 109]. This 
pathway was first reported in mammalian cells in 1986 and to this date not much is known 
about its molecular components [114]. Several proteins that have key roles in other repair 
pathways including homologous recombination have been implicated such as Poly (ADP-Ribose) 
Polymerase I (PARP1), NBS1, MRE11, CtIP, DNA Ligase III (LigIII) and Ligase I (LigI), XRCC1 [113, 
115-118]. CTIP interacts with MRE11 and both function in DNA end-resection during 
homologous recombination [113, 118-122]. MRE11 has 3’ to 5’ exonuclease activity but it can 
also open DNA hairpin loop [123]. MRE11 overexpression is associated with increase in A-NHEJ 
and its interaction with DNA LigIII/XRCC1 is increased after DNA damage induction in DNA LigIV-
deficient cell lines [120, 124]. Yun and Hiom revealed that CtIP is required for microhomology-
mediated en joining (MMEJ) in an avian B cell line in the G1 phase of the cell cycle [122]. DNA 
LigIII, XRCC1 and PARP1, are usually involved in ssDNA repair [118, 124]. Currently, the 
molecular components as well as activation and regulation of this pathway are poorly 
understood, and thus need to be investigated in detail. 
DNA damage response factors in V(D)J recombination. 
Although largely dispensable for V(D)J recombination, ATM is localized to the RAG-induced 
breaks  indicating that it plays some role during V(D)J recombination [125]. Similarly, other DDR 
proteins including MRE11, NBS1 and γH2AX are not required for normal V(D)J recombination. 
However, loss of these proteins increases interchromosomal rearrangements and chromosomal 
deletions at the antigen receptor loci [126-128]. The mechanisms underlying these end-joining 
defects are discussed in detail in section 1.11. In brief, ATM kinase activity has been suggested 
to play important roles in maintaining post-cleavage complex stability during V(D)J 
recombination, most likely by modulating the DNA tethering activity of its downstream targets 
including MRN complex and/or by regulating chromatin modifications through γH2AX [127, 
129].  Altogether, ATM, MRE11, H2AX and NBS1 are not essential for normal V(D)J 
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recombination but are more likely important to prevent misrepair of the RAG-breaks and 
genomic instability.  
A-NHEJ is not utilized during normal V(D)J recombination [106]. [118] However, the 
contribution of this pathway to V(D)J recombination may be masked by intact C-NHEJ and 
needs to be further characterized. It has been shown to play a role in aberrant V(D)J 
recombination. MRE11 and CtIP have been implicated in error-prone alternative end-joining 
during the G1 phase of the cell cycle [121, 124, 126]. NBS1 is required for alternative end 
joining of hairpin coding ends [118]. CtIP also promotes end resection of RAG-generated breaks 
via MMEJ in the absence of H2AX and this resection is dependent on ATM kinase [126]. In 
summary, there is some evidence for the role of DDR during V(D)J recombination but the 
regulation of these process is still not entirely understood and needs to be defined in the 
context of both the normal and aberrant rearrangements.  
1.9 Inherited Defects in V(D)J Recombination and Human Disease 
Primary immunodeficiences. 
This includes a broad spectrum of diseases ranging from Severe Combined Immunodeficeincy 
Disorder (SCID) to combined immunodeficiency [130, 131]. Defective V(D)J recombination is 
responsible for about 30% of cases. These patients present with recurrent respiratory and 
gastrointestinal infections with a failure to thrive at an early age. These infections are 
frequently caused by opportunistic organisms (Pneumocystis carinii; Aspergillus) and viruses 
(Cytomegalovirus). The life expectancy is usually less than a year unless the patient receives a 
successful bone marrow transplant [132]. 
Null and hypomorphic mutations in RAG1, RAG2 or C-NHEJ genes lead to primary 
immunodeficiencies. RAG mutations are responsible for 10% of all SCID cases reported [133]. 
The autosomal recessive disorder due to RAG deficiency usually leads to classical T-B- SCID. The 
carrier individuals with heterozygous mutations have no immunological deficiencies (MIM 
#179615 and #179616).  
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Defects in C-NHEJ factors lead to immunodeficiency with general DNA repair defect and  
cellular sensitivity to ionizing radiation, a condition known as Radiosensitive (RS)-SCID (Table 
1.2) [131, 134]. Molecular and genetic analyses of the patient cell lines and experimental animal 
models were instrumental in the discovery of many DNA repair factors, including Artemis [135]. 
At least 48 different immunodeficiency-associated mutant Artemis alleles have been identified 
and most of these mutations affect the N-terminus catalytic domain [136, 137]. Null mutations 
usually lead to T-B-NK+ SCID. Patients with hypomorphic mutations present with varying degree 
of immunodeficiency (B-/lowT-/low SCID) due to residual V(D)J recombination activity.  
Defects in other C-NHEJ factors have also been reported. A misense mutation in PRKDC, the 
gene that encodes DNA-PKcs, results in a mutant protein (p.Leu3062Arg) that reduces Artemis 
endonucleolytic activity [138]. LIG4 mutations leads to SCID or Ligase IV syndrome 
characterized by immunodeficiency, chromosomal instability, growth retardation, microcephaly 
and unusal facies (distinct facial features associated with a medical condition) (Table 1.2) [139, 
140]. XLF mutations also cause immunodeficiency, bird-like facies, growth retardation and 
microcephaly [141]. There are no known defects in Ku70/80. 
Omenn syndrome. 
This is an autoimmune-like disorder characterized by a range of immunocompromised states 
associated with activated T lymphocytes of highly restricted TCR heterogeneity in the 
peripheral tissues, elevated levels of eosinophils and IgE, hepatosplenomegaly and 
lymphadenopathy [142]. These patients usually present with skin rash and colitis due to 
infiltration with the activated T lymphocytes, and alopecia (hair loss). It ultimately requires 
allogenic bone marrow transplant. 
It was first clinically described in 1965 by Gilbert Omenn [143]. Mutations in RAG1, RAG2 and 
Artemis genes responsible for this syndrome have only recently been identified [144-146]. 
These mutations are considered hypomorphic because of residual (> 1%) V(D)J recombination 
as compared to the wild-type levels and leaky lymphocyte development.  
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Table 1.2: Human Genetic Disorders Associated with Defects in C-NHEJ Factors 
 
Predisposition to lymphomas. 
Hypomorphic Artemis mutations. So far, no RAG1/2 mutations and no null Artemis mutations 
have been reported to be associated with tumors in humans. Two patients with hypomorphic 
Artemis mutations (D432fsX15, D451fsX10) developed aggressive EBV-associated lymphomas. 
These mutations result in premature truncation of C-terminus. Unlike other EBV-associated 
lymphomas, these patient tumors had clonal origins and features of genomic instability 
indicating distinct pathological mechanisms underlying tumorigenesis [147]. We generated a 
mouse model in our lab based on D451fsX10 mutation and elucidated the oncogenic 
mechanisms. The findings from that study will be discussed in detail in Chapter 2. 
LIG4 mutations. Hematological malignancies have been reported in patients with LIG4 
mutations. These include T cell leukemia (two cases), B cell lymphoma, myelodysplasia and 
EBV-associated lymphoma (one case for each tumor type) [139, 148, 149]. Recently, a patient 
diagnosed with Dubowitz syndrome at 1-year of age who developed squamous cell carcinoma 




ATM, NBS1 and MRE11 mutations. Germline ATM mutations result in Ataxia-Telangiectasia (AT) 
which is characterized by cerebellar ataxia, ocular telangiectasia,  lymphopenia, sensitivity to 
ionizing radiation and lymphoid tumors with translocations involving antigen receptor loci [151-
153]. NBS1 mutations result in Nijmegan breakage syndrome with IR sensitivity, 
immunodeficiency, chromosomal abnormalities and lymphomas very similar to those seen in 
AT patients [154, 155]. MRE11 mutations in patients (Ataxia-Telangiectasia like disorder) have 
been associated with translocations involving antigen receptor loci and solid tumors [100, 156]. 
No lymphomas resulting from germline MRE11 mutations have been reported so far.  
1.10 Mouse Models of Defective V(D)J Recombination 
RAG1-, RAG2- or Artemis-deficiency in mice recapitulates the patient phonotypes with T-B-SCID 
(RAG1/2-null mice) or T-/lowB- SCID (Artemis-null mice) [157, 158]. Lymphocytes are arrested at 
DN2/DN3 (T cells) and pro-B cell stage. RAG1- and RAG2-null mice do not develop any other 
anomalies. 
Mutant Ku70, Ku80, DNA-PKcs and Artemis mice exhibit cellular sensitivity to ionizing radiation 
along with defective lymphocyte development [157, 159-162]. Ku70 or Ku80-deficiency also 
leads to growth retardation and sterility whereas DNA-PKcs- and Artemis-defective mice are 
normal in size and fertile. This suggests that DNA-PKcs and Ku70/Ku80 function together as a 
complex but also have distinct functions. The lymphocytes in C-NHEJ-defective mice harbor 
unresolved hairpin coding ends. Low levels of joins that are formed in the absence of Artemis 
and DNA-PKcs are qualitatively distinct with extensive deletions and an increase in the number 
of P nucleotides. XRCC4 or LigIV deficiency leads to late embryonic lethality due to neuronal 
apoptosis [163].  
Two mouse models with mutant RAG1 (R972G) and RAG2(R229Q) proteins have been reported 
to develop features of Omenn Syndrome [164, 165].  
Lymphomagenesis in mice with defects in C-NHEJ & DNA damage response (DDR). 
Mice with C-NHEJ deficiency rarely present with lymphoid tumors most likely due to the p53-
mediated cellular apoptosis. Mice with combined C-NHEJ and p53 deficiencies develop pro-B 
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lymphomas with non reciprocal translocations involving IgH and c-Myc genes resulting in 
amplification of both genes [110]. Mice with only p53 deficiency develop lymphoid tumors 
most of which do not harbor chromosomal aberrations at the RAG breaks.   
Mice with defects in DNA damage response factors harbor elevated levels of genomic instability 
and unrepaired coding ends in their lymphocytes [129, 166]. ATM-deficient mice succumb to 
early onset thymic lymphomas similar to those observed in AT-patients [167-169]. These 
tumors bear chromosomal translocations involving the TCRα/δ locus. Targeted disruption of 
Nbs1 in mice also leads to development of lymphomas harboring similar rearrangements as 
seen in Atm-/- mice [170]. Combined H2AX and p53 deficiencies also lead to the development of 
B cell lymphomas harboring chromosomal translocations including IgH to c-Myc translocations 
[171, 172]. 
In our lab, two mouse models with hypomorphic Rag1 and Artemis mutations also developed 
lymphomas on a p53-deficient background providing the first in vivo evidence for roles of these 
proteins in preventing genomic instability. These studies are discussed in chapter 2.  
1.11 Misrepair of RAG Breaks and Tumorigenesis 
In addition to lymhomagenesis observed with the above-mentioned germline mutations, 
sporadic lymphoid tumors also frequently harbor recurrent structural chromosomal aberrations 
that result from mis-repair of RAG-breaks. These include translocations, deletions and 
inversions, all of which require DNA DSBs. Some of the most recurrent translocations are (1) 
t(14;18)-BCL-2/IgH in follicular lymphomas, (2) t(8;14)-c-MYC/IgH translocations in Burkitt’s 
lymphoma (3) t(11;14)-BCL-1/IgH in mantle cell lymphoma [109, 110]. These recurrent events 
may result from selective pressures conferred by the deregulated expression of 
protooncogenes and/or spatial proximity bias for their formation. Chromosomal deletions and 
inversions may result if two DSBs are located on the same chromosome. In this section, I will 
discuss the mechanisms associated with germline and somatic defects that lead to misrepair of 
DNA breaks and genomic instability during V(D)J recombination. A combination of these factors 
along with loss of checkpoints contributes to tumorigenesis.  
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Substrate recognition errors. 
Millions of cryptic RSSs have been identified in human and mouse genomes. These sequences 
resemble RSSs and are found in non-antigen receptor regions [173]. Many gene partners of 
antigen receptor loci in oncogenic translocations have breakpoints at these cryptic RSSs [173, 
174]. Deletions and inversions of chromosomal segments at RSS-like sequences have also been 
observed in tumors. Deletion of MTS1, a tumor suppressor, in T-ALL (Acute lymphoblastic 
leukemia) contains a heptamer sequence at the breakpoint [175]. The broken chromosome 
ends are also joined by mechanisms suggestive of end-joining.  Joining of breaks at two cryptic 
RSS also leads to aberrant events such as interstitial deletion between SCL and SIL [176, 177]. 
Recent studies have suggested that RAG2 C-terminus is required to discriminate between the 
correct and cryptic RSSs [46].  Mice lacking non-core RAG2 C-terminus develop lymphomas [65]. 
Loss of this discrimination and H3K4me3 specificity might at least partially account for the 
features of genomic instability in this mouse model.   
Unusual structures like non-B DNA, when present adjacent to nonamer sequences, also serve as 
cleavage substrates for RAG complex [178, 179].  A non-B DNA structure located in BCL2 
genomic region is a major RAG cleavage target and generates t(14;18)BCL-2/IgH translocation.   
In biochemical assays, RAG1 can bind DNA in the absence of RAG2, [52]. The in vivo evidence 
for such binding is lacking and RAG1 would still require RAG2 for its catalytic activity. However, 
if RAG1 can non-specifically bind DNA independently of RAG2 in phases when RAG2 is not 
present (S/G2/M) in vivo, this may also contribute to aberrant cleavage through other 
uncharacterized mechanisms.   
Post-cleavage complex (PCC) Stability. 
The cleaved DNA ends are held in complex with RAG and other proteins within PCC which 
ensures that ends are directed specifically to C-NHEJ pathway. Insight into the functions of 
RAG1/2 in maintaining PCC structural integrity was offered by genetic studies that used 
separation-of-function RAG mutants, including RAG1 p.Ser723Cys and Ser723Ala mutants. 
These mutants retained cleavage activity but affected interaction with the coding ends after 
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cleavage [180].  Kumar and Swanson reported that full-length RAG1 enhances coding end 
retention in PCC in biochemical assays [181]. In the same study, the authors observed that a 
RAG1 p.Lys980Ala mutant forms coding joins characterized by long deletions, long P 
nucleotides and microhomologies. Lack of RAG2 C-terminus also predisposes to end-joining by 
the use of microhomologies and deletional hybrid joins in mice [65]. This suggests that ends 
released prematurely from PCC do not engage in proper end-joining and are available for 
joining by error-prone A-NHEJ. Over the last seven years, other proteins that were previously 
considered dispensable for V(D)J recombination, have been implicated in maintaining PCC 
stability and suppressing chromosomal translocations at RAG breaks. These include ATM, MRN 
complex, and H2AX [127, 129, 182]. These studies provide a potential explanation for the 
development of translocations involving RAG breaks in cells with mutations in ATM, NBS1 and 
MRE11 genes.  ATM-, NBS1- and H2AX- deficient mice also exhibit translocations involving 
antigen receptor loci in non-tumor cells and develop thymic lymphomas with αδ-translocations 
[170]. Presence of hybrid joins associated with aberrant deletional recombination in ATM-, 
MRE11-, and NBS1-deficient pre-B lymphocytes further supports this hypothesis [127, 129]. 
ATM has been suggested to mediate this effect by regulating DNA end tethering by MRN 
complex and H2AX-dependent chromatin modification along the cleaved DNA ends [182]. H2AX 
also prevents CtIP-mediated end-resection in an ATM-dependent manner [126]. 
Our lab showed the first in vivo evidence for a role of RAG1 and Artemis proteins in PCC 
stability and lymphomagenesis by examining the effect of hypomorphic mutations in these 
genes on V(D)J recombination. The findings from these studies are discussed in detail in 
Chapter 2.  
Repair pathway choice. 
Many chromosomal translocation breakpoints in hematological malignancies, and some solid 
tumors, show microhomologies indicating an active role of A-NHEJ in catalyzing translocations  
[110, 183]. Tumors associated with combined C-NHEJ- and p53- deficiencies in mice also harbor 
translocations that are RAG-dependent and exhibit microhomologies at the breakpoint 
junctions [184].  
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Why do translocations show increased use of A-NHEJ mechanisms? The underlying mechanisms 
for this preference are not entirely clear. Genome-wide analysis to compare translocations 
involving I-SceI-generated breaks between C-NHEJ deficient and wild-type cells did not show 
any significant qualitative differences. Thus, translocations may favor use of A-NHEJ over C-
NHEJ even in wild-type cells [110]. In addition, A-NHEJ is active in lymphocytes with Rag2 
mutations that have intact C-NHEJ indicating that the two pathways co-exist in cells [65, 185]. 
Breaks that persist may undergo resection making them vulnerable to microhomology-
mediated end-joining which may be less biased towards intrachromosomal joining. CtIP-
dependent resection of coding ends in H2AX-deficient lymphocytes has been shown to promote 
the use of microhomologies [126]. 
DNA damage response. 
In addition to stabilizing RAG breaks, ATM also plays important roles in activating checkpoints in 
response to DSBs generated by ionizing radiation and other genotoxic agents to ensure proper 
repair. Defects in ATM-mediated checkpoint activation results in persistence of the DSBs in the 
mature cells where they can be joined aberrantly.  The breaks that persist through cell cycle 
may also join with DSBs produced during class switch recombination in mature B lymphocytes. 
Tumor suppressor p53-mediated apoptosis also suppresses lymphomagenesis as indicated by 
development of pro-B lymphomas with IgH/c-Myc co-amplification in C-NHEJ- and p53-deficient 
mice.  
1.12 Concluding Remarks 
Generation of DNA DSBs during V(D)J recombination is integral to lymphocyte development. 
Thus, several spatiotemporal regulatory mechanisms are active in developing lymphocytes to 
maintain genomic stability. Defects at each step of this process can lead to misrepair of the RAG 
breaks. A combination of these defects will eventually result in malignant transformation.  An 
understanding of mechanisms underlying tumorigenesis in the developing lymphocytes is 
essential to improve the prognosis and clinical outcome in patients. Mouse models based on 





Spontaneous Genomic Instability and Lymphomagenesis in Mice Harboring Hypomorphic 
RAG1 and Artemis Mutations 
 
2.1 Abstract 
As discussed in Chapter 1, RAG1/2 and Artemis endonucleases play essential roles 
during V(D)J recombination by generating DNA double-strand breaks at specific recombination 
signal sequences and opening hairpin coding ends, respectively. Inactivating RAG and Artemis 
mutations cause a human severe combined immunodeficiency syndrome (SCID) characterized 
by arrested lymphocyte development due to impaired V(D)J recombination. This is also 
associated with cellular radiosensitivity in case of Artemis mutations. Hypomorphic mutations 
in these genes result in combined immunodeficiency or Omenn syndrome. Hypomorphic 
Artemis mutations associated with deletion of C-terminus, such as Artemis-P70 (D451fsX10), 
also predispose to lymphomas with clonal translocations in patients. The molecular 
mechanisms underlying tumor development in these patients are not clear. To date, no RAG 
mutations associated with human malignancy have been reported. However, in vitro 
biochemical and cellular transfection studies suggest that RAG1/2 may play postcleavage roles 
by forming complexes with the recombining ends to facilitate DNA end processing and ligation. 
In this regard, RAG1-S723C mutant protein was shown to be proficient for DNA cleavage, but 
defective in postcleavage complex formation and end joining in vitro. DNA ends prematurely 
released from end-complexes may undergo aberrant rearrangements such as chromosomal 
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translocations and deletions. To examine the roles of these mutations in aberrant V(D)J 
recombination and tumor predisposition, our lab has developed two knock-in mouse models- 
one harboring Artemis-P70 mutation and the other with RAG1-S723C mutation. Both RAG1-
S723C and Artemis-P70 mutant mice exhibit reduced V(D)J rearrangements, impaired 
lymphocyte development and accumulation of DNA ends in developing lymphocytes. In the 
current study, we examined the fate of unrepaired and/or unprotected DNA ends in the 
developing lymphocytes harboring these hypomorphic mutations in order to gain insights into 
the mechanisms involved in proper DNA end processing and joining. We demonstrate that 
these mutations spontaneously lead to increased aberrant V(D)J joining events and predispose 
to thymic lymphomas associated with chromosomal translocations in a p53 mutant 
background. Tumors associated with Artemis-P70 mutation are distinct from those observed 
with Artemis nullizygosity in molecular defects, tumor spectrum and oncogenic chromosomal 
rearrangements. Thus, our study provides in vivo evidence that implicates partial loss-of-
function alleles of Rag1 and Artemis in aberrant end-joining, genome instability and tumor 
development. 
2.2 Introduction 
The immense diversity of genes encoding the variable regions of antigen receptors is 
generated through rearrangement of component V, D, and J segments via a cut-and-paste 
mechanism known as V(D)J recombination [186]. These site-specific chromosomal 
rearrangements are initiated in progenitor lymphocytes by the recombination activating gene 1 
(RAG1) and RAG2 proteins that comprise a lymphoid-specific endonuclease, RAG1/2 [4, 5]. DNA 
double-strand breaks (DSBs) are generated by RAG1/2 at specific recombination signal 
sequences (RSSs) adjacent to the numerous rearranging V, D, and J coding exons [21]. The 
broken ends are then processed and joined by ubiquitously expressed nonhomologous end-
joining (NHEJ) DNA repair factors, including Ku70, Ku80, the DNA-dependent protein kinase 
catalytic subunit (DNA-PKcs), Artemis, DNA ligase IV, XRCC4 and Cernunnos/XLF [13, 14, 186].  
The RAG1/2 endonuclease initially binds to RSSs that are composed of a conserved heptamer 
and nonamer separated by relatively nonconserved spacer sequences of either 12 or 23 
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nucleotides [21]. Efficient cleavage requires recombination between one 12 RSS and one 23 RSS 
in the context of a synaptic, paired complex mediated by RAG1/2. RAG1/2 nicks the duplex DNA 
at the junction between the RSS heptamer and coding sequences then uses the resulting 3′ OH 
in a direct transesterification reaction with the phosphodiester backbone of the opposing 
strand. The products of RAG1/2 cleavage are blunt, 5′ phosphorylated signal ends and 
covalently closed, hairpin coding ends. Sequence elements within the nonconserved 12 and 23 
spacers [187] and coding flanks [188-191] contribute to RAG1/2 interaction with the 
recombining DNA and strongly influence coding segment utilization [187]. Hence, the efficiency 
of binding and cleavage of individual RSSs is significantly affected by interactions of the RAG1/2 
endonuclease with the heptamer, nonamer, 12 or 23 spacer, and coding sequences. 
In addition to an essential role in the cleavage phase, RAG1/2 has also been suggested 
to possess post-cleavage functions during V(D)J recombination. In vitro biochemical and cellular 
transfection assays suggest that the RAG proteins are associated with the DNA ends in post-
cleavage complexes [3, 34, 61, 180, 192-197]. RAG1/2 and the four DNA ends (two coding and 
two signal) form a transient cleaved signal complex (CSC) [34, 61, 180]. This complex may 
protect the coding ends from degradation and specifically direct them to C-NHEJ pathway. The 
coding ends, on release from the CSC, are rapidly processed and joined with junctional 
modifications. The signal ends remain associated with RAG1/2 in a stable signal end complex 
(SEC) until they are precisely ligated by the C-NHEJ factors to form signal joins [34, 193, 194].  
Further evidence for important RAG1/2 post-cleavage roles is provided by separation-
of-function mutations in RAG genes [180, 195-197]. A RAG1 mutant protein of our interest 
contains alanine or cysteine instead of serine at 723 position [180]. Biochemical assays showed 
that this mutant protein was proficient in cleavage activity [180, 198] but was defective in CSC-
stability manifested as premature release of coding ends [180]. In transient V(D)J 
recombination assays using RAG1-S723C mutant protein, formation of both signal and coding 
joins was significantly reduced despite no obvious abnormality in interaction with signal ends 
[180, 192, 199]. However, the in vivo consequences of these mutations and post-cleavage 
complex instability still remain to be characterized.  
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To examine the in vivo effect of RAG1-S723C mutant in our lab, a mouse model 
harboring this mutation was generated [200]. These mice exhibit a significant impairment in 
lymphocyte development at stages when V(D)J rearrangements occur. In contrast to RAG1- and 
RAG2-null mice, the phenotypes of RAG1-S723C mice more closely parallel those of human 
leaky T+B-SCID [130]. In addition, low levels of D to J rearrangements were observed in the 
developing lymphocytes. Hence, mice harboring the RAG1-S723C hypomorphic allele can be 
clearly distinguished from RAG nullizygosity by the ability to catalyze a low level of productive 
V(D)J recombination events in vivo. DNA DSBs were readily detected in the mutant lymphocytes 
indicating that the cleavage activity of RAG1-S723C/RAG2 complex is intact. Cleavage products 
not corresponding to the expected sizes were also observed in these lymphocytes. These 
aberrant products can result from either aberrant DNA cleavage and/or premature end release 
[23, 158, 160, 162, 201-204]. Other studies have also found Omenn syndrome-like features in 
RAG1-S723C homozygous mice autoreactive B cell repertoire [205].  
The role of Artemis in V(D)J recombination is discussed in detail in sections 1.2 and 1.4. 
Prior to ligation, the hairpin coding ends are nicked open by the Artemis endonuclease which is 
activated upon interaction with the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) 
[79]. In the absence of Artemis function, unopened hairpin coding ends accumulate in 
developing lymphocytes and remain unjoined resulting in defective V(D)J recombination [158].  
To date, at least 48 different mutant Artemis alleles have been identified in association 
with inherited combined immunodeficiency syndromes [136, 137]. The majority of mutations 
are located within a region encoding a highly conserved metallo-β-lactamase/βCASP N-terminal 
domain (aa 1–385). A smaller subset of Artemis alleles resides within a non-conserved C-
terminus (aa 386–692), and these mutations are small nucleotide deletions or insertions 
resulting in frameshifts followed by premature translation termination. Patients harboring null 
mutations suffer from an absence of B and T lymphocytes, whereas partial loss-of-function 
Artemis alleles are associated with immunodeficiency syndromes of varying severity, including 
B−/lowT−/low SCID, B−/low SCID, chronic inflammatory bowel disease and Omenn syndrome [69, 
136, 137, 145, 147, 206-215]. The unjoined DNA ends that accumulate in lymphocytes due to 
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defects in the NHEJ pathway can be misrepaired via alternative repair pathways, thereby 
leading to genome instability and potentially detrimental chromosomal aberrations, including 
oncogenic translocations [216].  
Patients harboring Artemis mutations that result in premature translation termination 
within exon 14 leading to truncation of C terminus (D451fsX10) have been identified. This 
mutation will be referred to as P70, herein [147]. These patients develop partial B and T 
immunodeficiency and aggressive Epstein-Barr virus (EBV)-associated lymphomas. However, 
these tumors are distinct from general EBV-associated tumors on molecular analysis. These 
tumors (1) were of clonal origin, as shown by the rearrangement status of IgH locus, and (2) 
harbored chromosomal anomalies with increased genomic instability [147]. This suggests a 
potential onocgenic role of hypomorphic Artemis mutations. However, it is not yet established 
whether hypomorphic Artemis mutations predispose to lymphomas. Null Artemis mutations 
have not been reported to predispose to lymphomas in humans. This further raises the 
possibility that partial loss of function mutations resulting in C-terminus truncation may have 
greater oncogenic potential than null alleles.  
The C-terminal domain interacts with DNA-PKcs and contains phosphorylation sites for 
DNA-PKcs [17, 71, 74]. The Artemis:DNA-PKcs complex contains endonucleolytic activities to 
cleave DNA at single-to-double-strand transitions, including hairpins and 5’ or 3’ overhangs [15, 
75, 79, 217], as well as single strands [218]. However, DNA-PKcs dependent phosphorylation is 
not essential for activation of endonucleolytic activity in biochemical assays using site-specific 
mutations in Artemis C-terminus [17]. Artemis mutations with C-terminus truncations that 
retain stable Artemis:DNA-PKcs interaction but lack majority of phosphorylation sites, including 
Art-P70, exhibit reduced DNA-PKcs dependent endonucleolytic activity [75, 82]. Our lab has 
previously shown that a mouse model harboring the Art-P70 mutation recapitulates partial 
immunodeficiency phenotypes observed in patients [82]. Our lab determined that impaired 
lymphocyte development resulted from a substantial reduction in Artemis-mediated hairpin 
opening. These findings indicate that Artemis C-terminal domain has important function in 
modulating Artemis activities and facilitating DNA-PKcs interaction. 
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In the following study, we examine the in vivo impact of the RAG1-S723C and Art-P70 
mutations on aberrant V(D)J rearrangements and tumorigenesis in two different mouse 
models.  We show that RAG-induced breaks spontaneously engage in aberrant 
interchromosomal trans-rearrangements in RAG1-S723C and Art-P70 non-malignant 
lymphocytes. We also observe chromosomal deletions at the antigen recptor loci in Art-P70 
lymphocytes. Moreover, both mutations result in predisposition to thymic lymphomas 
associated with chromosomal translocations on a p53 mutant background, with Art-P70 
associated tumors being molecularly distinct from those associated with Artemis-nullizygosity. 
These findings provide insight into the potential roles of these protein in maintaining DNA end 
complex stability during V(D)J recombination and have important implications for  
tumorigenesis. 
2.3 Results 
RAG1-S723C and Artemis-P70 mutants lead to interchromosomal trans-rearrangements in 
non-malignant primary thymocytes. 
We previously observed accumulation of DNA ends in Rag1S723C/S723C and ArtP70/P70 lymphocytes 
[82, 200]. To determine if unjoined DNA ends can engage in aberrant rearrangements, I 
examined trans-rearrangements between two T-cell receptor loci, TCRγ and TCRβ which are 
located on mouse chromosomes 13 and 6, respectively. TCR Vγ to Jγ and TCR Dβ to Jβ segments 
are actively rearranged in the DN2/DN3 cells, [219] and may recombine aberrantly. 
Interchromosomal trans-rearrangements indicate global chromosomal translocations and are 
observed at higher frequencies in T lymphocytes harboring mutations in genes that predispose 
to lymphoid neoplasia, including ATM, DNA-PKcs, NBS1 and 53BP1 [170, 220-223]. I used 
nested PCR and Southern blot analyses to detect PCR products corresponding to 
transrearrangements between two specific segments, TCRγV3S1 and TCRβJ2 in RAG1-S723C 
and Art-P70 homozygous mutant thymocytes (Figure 2.1A). As previously shown, we detected 
robust levels of transrearrangement between TCRγ and TCRβ in ATM-null thymocytes [167, 
220, 221, 224, 225] (Figure 2.1B). PCR products corresponding to interchromosomal V(D)J 
rearrangements in wild-type or p53−/− thymocytes were not readily observed, as previously 
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reported [170, 200, 224] (Figure 2.1A). In contrast, PCR products were readily observed in 
Rag1S723C/S723C but not in Rag2-/- thymocytes (Figure 2.1A).  
Figure 2.1: Aberrant Trans-rearrangements in Rag1-S723C Lymphocytes 
 
 
(A) Intrachromosomal TCRγ V-to-J (chr. 13) and TCRβ Dβ2-to-Jβ2 (chr 6) rearrangements and 
TCRγV–TCRβJ transrearrangements were PCR amplified from genomic thymocyte DNA isolated 
from mice of the indicated genotypes. PCR products were detected by Southern blot analysis. 
Levels of rearrangements were normalized to PCR-amplified non-rearranging locus. 
Representative results are shown. (B) TCRγV–TCRβJ transrearrangements (top panel) in wild-
type (WT), Atm-/-, Rag1S723C/S723C (S723C), Rag2-/- and p53-/- thymocytes. PCR products were 
subcloned and sequenced (bottom panel). Coding sequences are shown in boxes. Nucleotides 
added include P nucleotides (underlined) as well as N nucleotides. (B). Transrearrangement PCR 
products were sequenced and represented here, as described above. 
 
In case of Art-P70 mice, we initially examined levels of normal TCRγ V-to-J and TCRβ D-
to-J rearrangements by PCR amplification. As previously reported, we observed that TCRβ D-to-




thymocytes [82, 158] (Figure 2.2A, top panel). In comparison, products corresponding to TCRγ 
intrachromosomal V-to-J rearrangements were not significantly decreased in ArtP70/P70 and 
Art−/− thymocytes compared with controls. These findings indicate that the Art-P70 and null 
mutations impair rearrangement at the TCRγ locus to a lesser extent compared with TCRβ 
rearrangements, as has been observed at the TCRδ locus in NHEJ-deficient backgrounds, 
including Artemis nullizygosity [22, 118, 161, 226].  
Next, we determined whether transrearrangement occurs between TCRγV3S1 and 
TCRβJ2 (Figure 2.2A, bottom panel). Similar to Atm−/− lymphocytes, we detected substantially 
increased levels of interchromosomal events involving TCRγV3S1 and TCRβJ2 in ArtP70/P70 
thymocytes (n= 5 mice) compared with controls (Figure 2.2A, data not shown). On the contrary, 
we observed a lower frequency of transrearrangement in Art−/− thymocytes. In this regard, two 
of seven Artemis-null mice harbored PCR products corresponding to TCRγ-to-TCRβ 
interchromosomal rearrangements (Fig. 2.2A, data not shown), and the events appeared to be 
clonal as only a single band was observed, compared with multiple bands observed in ArtP70/P70 
and Atm−/− thymocytes. Thus, the Art-P70 mutation increases the propensity of unrepaired 
coding ends to engage in aberrant interchromosomal translocations involving rearranging V(D)J 
loci. Moreover, this phenotype is distinct from that observed in Artemis-null thymocytes which 
exhibit infrequent transrearrangements despite harboring a higher level of unjoined hairpin 
coding ends [82].  
We next examined the frequency of interchromosomal rearrangements in Art-P70 
heterozygous thymocytes to determine whether the hypomorphic mutation results in a 
dominant phenotype. TCRγV3S1 to TCRβJ2 transrearrangements were readily detected in 
Art+/P70 thymocytes in more than half (six of ten) of the mice examined (Figure 2.1C). However, 
fewer PCR products corresponding to distinct rearrangements and lower levels of 
interchromosomal events were observed in Art+/P70 compared with ArtP70/P70 and Atm−/− 
thymocytes. The levels of TCRβ D-to-J rearrangements in Art-P70 heterozygous thymocytes 
were similar to those observed in wild-type controls (Figure 2.3). These findings indicate that 
the C-terminally truncated Art-P70 protein does not substantially disrupt proper coding end 
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processing and joining, yet increases chromosomal anomalies, even when the wild-type enzyme 
is present.  
Figure 2.2: Aberrant Trans-rearrangements In Art-P70 Lymphocytes 
 
 
Intrachromosomal TCRγ V-to-J (chr. 13) and TCRβ Dβ2-to-Jβ2 (chr 6) rearrangements and 
TCRγV–TCRβJ transrearrangements were PCR amplified from genomic thymocyte DNA isolated 
from mice of the indicated genotypes. PCR products were detected by Southern blot analysis. 
Levels of rearrangements were normalized to PCR-amplified non-rearranging locus. 
Representative results are shown. (A) TCRγ V-to-J and TCRβ Dβ2-to-Jβ2 rearrangements (top) 
and TCRγV–TCRβJ transrearrangements (bottom) in WT, ArtP70/P70, Art−/−, Atm−/− and p53−/− 
thymocytes. GL, germline, unrearranged band; R, bands corresponding to rearrangements; C or 
Kid, PCR amplification of kidney genomic DNA. (B). Transrearrangement PCR products were 






Figure 2.3: Aberrant Trans-rearrangements In Art+/P70 Lymphocytes 
  
Intrachromosomal TCRγ V-to-J (chr. 13) and TCRβ Dβ2-to-Jβ2 (chr 6) rearrangements and 
TCRγV–TCRβJ transrearrangements were PCR amplified from genomic thymocyte DNA isolated 
from mice of the indicated genotypes. PCR products were detected by Southern blot analysis. 
Levels of rearrangements were normalized to PCR-amplified non-rearranging locus. 
Representative results are shown. (A) Examination of TCRγ V-to-J, TCRβ Dβ2-to-Jβ2 (top) and 
interchromosomal TCRγV–TCRβJ transrearrangements (bottom) in Art+/P70 mice.  
 
The nested PCR products from RAG1-S723C and Art-P70 mutant thymocytes were 
cloned and sequenced in order to verify that they represent the predicted interchromosomal 
events. We obtained several unique clones from RAG1-S723C and  ArtP70/P70 mice (n=4) 
containing flanking sequence from TCRγV3S1 and TCRβJ2, thereby indicating that the PCR 
primers indeed amplified V(D)J transrearrangements (Figure 2.1B, bottom panel; Figure 2.2B). 
The junctions contained non-templated (N) and palindromic (P) nucleotides and small 
deletions, similar to the coding joints analyzed from intrachromosomal V(D)J recombination 
events in the wild-type mice [82]. We also cloned and sequenced the PCR products 
corresponding to the interchromosomal rearrangements obtained from Art−/− thymocytes. 
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Sequencing of multiple clones yielded one unique sequence, thereby indicating that the single 
PCR product likely represents a clonal event (Figure 2.2B).  
These results support the notion that aberrant end processing due to RAG1-S723C and 
Art-P70 mutants  generate V(D)J ends that engage in chromosomal translocations. In Art-P70 
lymphocytes, these aberrant events occur at an elevated frequency compared with a complete 
absence of Artemis.  
Increased deletional chromosomal hybrid joining in Artemis-P70 mice. 
Hybrid joint formation occurs between a coding and a signal (RS) end and represents an 
unproductive V(D)J rearrangement. Inversional chromosomal rearrangements require that the 
two coding and two RS ends generated by the RAG endonuclease are maintained in proximity in 
order to facilitate coordinated processing and ligation. Increased levels of deletional 
chromosomal hybrid joining during inversional V(D)J rearrangement are hypothesized to result 
from inappropriate release of RAG-generated ends from DNA end complexes, thereby leading 
to the loss of the intervening genomic fragment, thus favoring the deletional event (refer to 
Figure 1.) [118, 128, 166]. Our observations of increased interchromosomal rearrangements in 
RAG1-S732C and Art-P70, but not Art−/− lymphocytes, led us to examine the frequency of 
deletional hybrid joining in these mutant backgrounds. To this end, we examined hybrid joint 
formation during immunoglobulin light chain kappa (Igκ) locus rearrangements in splenocytes. 
Productive rearrangement between Vκ6-23 and Jκ1 segments occurs via inversion; thus, hybrid 
joining results in deletion of the intervening DNA segment (Figure 2.2A).  
Using a nested PCR approach, we readily detected Vκ to Jκ hybrid joints in ArtP70/P70 
splenocytes in the majority (three of four) of mutant mice analyzed (Fig. 2.4A). The levels were 
lower than those observed in ATM deficiency, but markedly higher compared with wild-type 
and Art−/− splenocytes. We also observed decreased levels of Vκ to Jκ coding joining in Art-P70 
mutant splenocytes compared with controls; therefore, the relative frequency of deletional 
hybrid joining compared with inversional coding joining within the IgLκ locus is substantially 
increased by the Art-P70 mutation.  
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Within the TCRβ locus, Vβ14-to-DJβ2 rearrangements also occur via inversion; thus, we 
examined deletional hybrid joining between Vβ14 and Dβ2 via nested PCR. We detected 
increased levels of Vβ14–Dβ2 hybrid joints in ArtP70/P70 thymocytes (two of four), albeit at lower 
levels compared with ATM deficiency (Fig. 2.4B). Hybrid joints were not detected in Art−/− 
thymocytes, as previously reported (47) (Figure 2.4B). Given our findings that 
interchromosomal rearrangements were detected in Art+/P70 thymocytes, we assessed the 
impact of Art-P70 heterozygosity on Vβ14–Dβ2 hybrid joining (Figure 2.4B). We also detected 
hybrid joints in a subset of Art+/P70 mice examined (two of five), thereby providing additional 
evidence that the Art-P70 allele may have a dominant effect in promoting aberrant 
rearrangements. However, deletional hybrid join products were not readily detected in RAG1-






Figure 2.4: Deletional Hybrid Join Formation in Art-P70 Mice 
 
(A) Left panel: Schematic representation of nested PCR strategy for detecting coding and hybrid 
joints within the IgLκ locus. Relative orientation of Vκ6-23 and Jκ1 coding (rectangles) and RSSs 
(triangles) within the IgLk locus. Inversional (CJ) and deletional (HJ) products are depicted. 
Positions of primers (J = pκJa, A = pκ6a, B = pκ6b, C = pκ6c, D = pκ6d) and probe (P) are shown. 
Right panel: PCR analysis of Vκ6-23 to Jκ1 coding joins (CJs) and hybrid joins (HJs). Genomic 
splenocyte DNA was isolated from WT, Atm−/−, Art−/− and ArtP70/P70 mice and amplified using 
primers (pκJa and pκ6d for CJ and pκJa and pκ6a for HJ). Serial 4-fold dilutions of the PCR 
reaction were amplified using nested primer pairs (pκJa and pκ6c for CJ, and pκJa and pκ6b for 
HJ). CJ and HJ bands are 0.6 and 0.25 kb, respectively. (B) Deletional hybrid joining and coding 
joining within the TCRβ locus. Upper panel: Schematic of nested PCR strategy. Relative 
orientation of Vβ14, Dβ2 and Jβ2.3 coding (rectangles) and RSSs (triangles) within the TCRβ 
locus. Positions of primers (I = pβa, II = pβb, III = pβc, IV = pβd, V = pβe, VI = pβf) and probe (P = 
pβg) are shown. Lower panel: PCR analysis of Vβ14 to Jβ2 coding and hybrid joints. Left panel 
shows CJ and HJ PCR analyses of genomic thymocyte DNA isolated from WT, ATM−/−, Art−/− and 
ArtP70/P70 mice. Right panel shows CJ and HJ PCR analyses of Art+/P70 and control thymocyte 
genomic DNA, as indicated. Primers for CJ were pβe and pβf. Primary primers for HJ were pβa 
and pβb. Serial 4-fold dilutions of this primary HJ reaction were amplified using primers pβc and 
pβd. CJ and HJ bands are 0.3 and 0.9 kb, respectively. PCR amplification of a non-rearranging 





Tumor predisposition in RAG1-S723C and Art-P70 mice. 
The occurrence of TCRγ-TCRβ trans-rearrangements in Rag1S723C/S723C and Art-P70 
thymocytes suggested that DSBs generated by the mutant RAG1/2 and Artemis proteins could 
engage in aberrant chromosomal translocations; thus, we examined the mutant mice for tumor 
predisposition.  
RAG1-S723C mice. 
We observed that the RAG1-S723C homozygous mutation alone does not predispose to 
tumorigenesis, as the mutant mice survive tumor free beyond 12 months of age. To enhance 
the oncogenic potential of unrepaired DNA DSBs, we introduced p53 deficiency into the RAG1-
S723C mutant background through mouse breedings. We observed that Rag1S723C/S723Cp53−/− 
mice exhibit a significant decrease in survival in comparison with the p53−/− cohort 
(Rag1+/S723Cp53−/− and Rag1+/+p53−/− mice; P = .017, log-rank test) and controls (P < .001) (Figure 
2.5A). All of the Rag1S723C/S723Cp53−/− mice succumbed to tumorigenesis, and the majority of 
tumors observed were immature TCRβ− T-cell lymphomas (90%, Table 2.1). In comparison, 
although the control p53−/− cohort was also predominantly predisposed to T-cell lymphomas 
(66%, Table 2.1), [227, 228] the majority of these tumors (16 of 23 thymic lymphomas) were 
surface TCRβ+, indicating they emanated from later stages of T-cell development compared 
with the RAG1-S723C/p53 mutant tumors (P < .001, 2-tailed Fisher exact test). Solid tumors and 
surface IgM+ B-cell lymphomas were frequently observed in the p53−/− cohort (12 of 35 tumors), 
whereas 3 of the 31 mice in the Rag1S723C/S723Cp53−/− cohort succumbed to solid tumors (P = .02, 
2-tailed Fisher exact test), and no lymphoid tumors other than TCRβ− T-cell lymphomas were 
observed (Table 2.1). 
Artemis-P70 mice. 
We examined cohorts of ArtP70/P70, Art−/− and wild-type mice over a period of 12 months 
to determine whether the Art-P70 mutation predisposes to lymphoid or other tumors. We 
observed that two of fourteen ArtP70/P70 mice became moribund at 7 and 9 months of age as a 
result of large thymic masses (Figure 2.5B). Flow cytometric analyses revealed that the thymic 
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lymphomas were primarily of a CD4+CD8+TCRβ− origin (Table 2.2). In comparison, the wild-type 
and Art−/− control cohorts survived tumor-free within the 12-month period, which is consistent 
with previous reports (53,54).  
To further assess the oncogenic potential of the Art-P70 hypomorphic allele, we 
examined the impact of p53 mutation on tumor predisposition through mouse breeding. The 
experimental cohorts were on a closely matched 129Sv/C57Bl6 background, thereby minimizing 
potential strain background effects. However, a subtle impact of genetic background cannot be 
entirely ruled out. Inactivation of the p53-dependent cell-cycle checkpoint in Artemis mutant 
lymphocytes allows cells harboring unrepaired DSBs or activated oncogenes to survive [229-
233]. We observed that Art-P70/p53 double mutant mice exhibit significantly decreased 
survival compared with p53−/− controls (median survival of 11 and 18 weeks, respectively; P = 
0.001; Figure 2.5B). As previously reported, we found that Art−/−p53−/− mice also exhibited 
decreased survival compared with p53 null controls, and the median survival (13 weeks) was 
similar to that observed for Art-P70/p53 double-mutant cohort (Figure 2.5B). We found that 
the Art−/−p53−/− and ArtP70/P70p53−/− mice succumbed to lymphoid tumors. Flow cytometric 
analysis of the tumors revealed that Art−/−p53−/− mice were predominantly predisposed to 
disseminated B220+CD43+IgM− pro-B lymphomas, as has been previously reported [234] (Table 
2.2). In contrast, the majority of tumors that arose in the Art-P70/p53 double-mutant 
background were CD4+CD8+TCRβ− thymic lymphomas (Table 2.2). B220+CD43+IgM− pro-B 
lymphomas were also observed in ArtP70/P70p53−/− mice, similar to Art/p53 double null mice 
[234] (Table 2.2), albeit at a significantly lower frequency (P = 0.014; two-tailed Fisher's exact 
test). These findings indicate that the Art-P70 allele predisposes to lymphoid malignancies in a 
p53-deficient background, and the lymphoma spectrum observed in ArtP70/P70p53−/− mice is 











(A) Survival of a cohort of control (Rag1+/+, Rag1+/S723C, Rag1S723C/S723C, n = 39), p53−/− 
(Rag1+/+p53−/−, Rag1+/S723Cp53−/−, n = 35), and Rag1S723C/S723Cp53−/− (n = 31) mice was observed 
for a period of 35 weeks. Kaplan-Meier survival curves were compared using the 2-tailed log-
rank test with a 95% confidence interval (Rag1S723C/S723Cp53−/− vs p53−/− cohorts, P = .017; 
Rag1S723C/S723Cp53−/− vs control cohorts, P < .001). (B) Decreased survival of Art-P70/p53 mice. 
Survival of a cohort of wild-type (n= 11), Art−/− (n= 10), p53−/− (n= 11), ArtP70/P70 (n= 14), 
ArtP70/P70p53−/− (n= 13) and Art−/−p53−/− (n= 9) mice was observed for a period of 40 weeks. 
Shown are Kaplan–Meier survival curves representing the percentage of survival of cohort mice 
versus age in weeks. 
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Table 2.1: Tumor Spectrum in RAG1-S723C/p53 Mice 
 
 
Table 2.2: Tumor Spectrum in Art-P70/p53 Mice 
 
 
Distinct chromosomal anomalies associated with RAG1-S723C/p53 and Art-P70/p53 lymphoid 
tumors.  
We analyzed the rearrangement status of the TCRβ locus in the Rag1S723C/S723Cp53−/−, 
ArtP70/P70p53−/− and ArtP70/P70 lymphomas to assess the molecular events that occurred in the 
tumors. We performed Southern blot analyses of EcoRI-digested genomic DNA isolated from 
the tumors using a probe located 5′ of Dβ1 (Figure 2.6A). The majority of Rag1S723C/S723Cp53−/− 
tumors exhibited D-Jβ1 rearrangements on one of the 2 alleles. As Dβ to Jβ rearrangements are 
severely reduced in Rag1S723C/S723C thymocytes [200], the relative intensities of the germline and 
rearranged bands observed in DNA isolated from tumor cells suggest that the rearrangements 
are clonal. We also examined the Dβ1 to Jβ1, Dβ2, and Jβ2 and Vβ8 to DJβ1 rearrangements in 
Rag1S723C/S723Cp53−/− tumors via PCR amplification and observed several tumors harboring 
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specific D-Jβ or V-DJβ rearrangements (Figure 2.6B). Together, these results indicate that the 
mutant RAG1-S723C/RAG2 endonuclease was active in generating DSBs in progenitor 
lymphocytes from which the tumors emanated, and the lymphomas are of a clonal origin.  
The ArtP70/P70p53−/− tumors were analyzed by another graduate student and the results 
are briefly summarized here. Thymic tumors and one pro-B tumor exhibited clonal 
rearrangements indicating the clonal origin of thymic, and some pro-B, lymphomas in Art-P70 
mice. One pro-B lymphoma showed N-myc locus amplification which is commonly associated 
with Art−/−p53−/− pro-B tumors. However, another ArtP70/P70p53−/− pro-B lymphoma with no 
genomic amplification of either c-myc or N-myc, showed elevated c-myc expression. These 
results indicate that the lymphomas arising in the Art-P70 arise via distinct mechanisms from 
null backgrounds.  
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Figure 2.6: Clonal Origin of Rag1-S723C/p53−/− Lymphomas 
 
(A) Genomic DNA isolated from RAG1-S723C/p53 double-mutant lymphomas was digested with 
EcoRI then analyzed by Southern blot. Dβ1 to Jβ1 rearrangements were detected using a probe 
located 5′ of the Dβ1 segment (diagram). Individual tumors are indicated, top. C indicates wild-
type thymus DNA; Kid, nonrearranging tissues; GL, unrearranged, germline band; and R, D-Jβ1 
rearrangements. Amounts of input DNA were normalized to a nonrearranging locus (LR8). (B) 
PCR amplification of Dβ1 to Jβ1, Dβ2 to Jβ2, and Vβ8 to DJβ1 rearrangements were performed 
using genomic DNA (250 ng) isolated from RAG1-S723C/p53 double-mutant lymphomas (tumor 
numbers indicated, top), wild-type thymocytes (C), and a nonrearranging tissue (tail). Input 
DNA levels were normalized to a nonrearranging locus (Atm). Vertical lines have been inserted 
to indicate repositioned gel lanes. 
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Cytogenetic analyses of RAG1-S723C/p53 and Art-P70/p53 double-mutant lymphomas.  
We next examined the cytogenetic events occurring in RAG1-S723C/p53 and Art-
P70/p53 double-mutant lymphomas using spectral karyotyping (SKY) , a multicolor 
chromosome painting technique. We analyzed the karyotypes of metaphases from primary and 
early passage cultured tumor cells. Thymic lymphomas that arise in p53-deficient mice usually 
feature aneuploidy without clonal translocations, [171, 172, 234-238] although clonal 
chromosomal aberrations have been observed in a small subset of p53−/− lymphomas in a mixed 
C57BL/6;129/Sv genetic background (M. Gostissa and F.W.A., unpublished). RAG-null mice in a 
p53 mutant background are also predisposed to thymic lymphomas [236, 239]; however, 
similar to the p53-null tumors, they are characterized by aneuploidy and do not harbor clonal 
translocations involving rearranging loci [236]. Thus, in the absence of RAG-induced DSBs, 
clonal translocations are not a common feature of the lymphomas in p53 deficiency. 
Furthermore, inactivation of NHEJ genes, which are required for joining of V(D)J ends, does not 
increase the frequency of oncogenic translocations in the RAG/p53 double-null background. In 
this regard, thymic lymphomas that arise in Ku80−/−Rag2−/−p53−/− mutant mice lack clonal 
translocations [235], and Xrcc4−/−Rag2−/−p53−/− mice die without any sign of lymphoma [232]. 
Interestingly, DNA-PKcs mutation in a Rag2−/−p53−/− background leads primarily to progenitor B-
cell malignancies associated with translocations involving chromosomes without V(D)J loci, 
[240] thereby leading to the notion that DNA-PKcs deficiency leads to accumulation of 
unrepaired random DSBs that engage in oncogenic events.  
We found that 6 of the 7 Rag1S723C/S723Cp53−/− lymphomas contained chromosomal 
translocations and/or short-arm fusions in a clonal population of tumor cells (Figure 2.7A; Table 
2.3). We observed 2 tumors with translocations involving chromosomes that harbor rearranging 
TCR loci (chr 6 and 14), suggesting that the clonal events were initiated by the mutant RAG1-
S723C/RAG2 endonuclease. Intriguingly, we also observed clonal translocations involving 
chromosomes lacking V(D)J loci. We also performed SKY analyses on several thymic lymphomas 
arising in Rag1+/S723Cp53−/− mice, as our analyses of lymphocyte development in older mice 
indicated that heterozygosity for the S723C mutation may confer additional phenotypes [200]. 
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We found that Rag1+/S723Cp53−/− lymphomas also harbored clonal chromosomal translocations 
(Table 2.3). The thymic lymphomas arising in our p53-null cohort were largely characterized by 
aneuploidy with one harboring a clonal translocation, consistent with previous studies [171, 
172, 234-238]. Thus, the RAG1-S723C/p53 thymic lymphomas featuring frequent clonal 
translocations and fusions are karyotypically distinct from the p53−/− lymphomas. 
The results from SKY analysis on metaphase spreads from seven ArtP70/P70p53−/− thymic 
lymphomas will be summarized here. All of the Art-P70/p53 tumors analyzed contained clonal 
translocations involving chromosomes that harbor loci undergoing V(D)J rearrangements 
including chromosome 12 (IgH), chr. 13 (TCRγ), and chr. 6 (TCRβ) (data not shown).  
 
Figure 2.7: Rag1-S723C/p53 and Art-P70/P53 Mice are Predisposed toTumors Harboring 
Chromosomal Translocations 
 
(A) Rag1S723C/S723Cp53−/− thymic lymphomas harbor chromosomal translocations and fusions. 
DAPI staining (left panels) and SKY analysis (right panels) of tumors S542 and S922 containing 
clonal chr 15;15 and 12;12 short-arm fusions and t(14;8) translocations, respectively. Arrows 
indicate translocated chromosomes. (B) SKY images of metaphase chromosomes from Art-
P70/p53 tumors. DAPI staining (left panels) and SKY analysis (right panels) of tumor C325 and 
C227 containing clonal t(4;14) and t(6;13) translocations, respectively. Arrows indicate 
translocated chromosomes.  
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Table 2.3: Spectral Karyotyping of Thymic Lymphomas in Rag1-S723C/p53 Mice 
 
 





In this study, we examined the impact of two hypomorphic mutations on aberrant V(D)J 
rearrangements and tumorigenesis in mice: RAG1-S723C mutant associated with unstable 
postcleavage complex in vitro and Artemis-P70 mutant that results in partial immunodeficiency 
and EBV-associated lymphomas in patients. We demonstrate that these mutations increase the 
frequency of aberrant chromosomal rearrangements in primary lymphocytes and predispose to 
lymphoid malignancy in mouse models. Thus, we reveal novel in vivo functions of RAG1 and 
Artemis proteins in maintaining genomic stability in the developing lymphocytes. 
Distinct tumor spectra and molecular events in RAG1-S723C/p53 and Art-P70/p53 mice. 
We demonstrate that RAG1-S723C/p53 double-mutant mice are predisposed to thymic 
lymphomas that harbor frequent chromosomal translocations. Two of the 7 
Rag1S723C/S723Cp53−/− tumors harbored chromosome 6 or 14 translocations, consistent with the 
notion that RAG1-S723C/RAG2-induced DNA DSBs at the rearranging TCR loci may engage in 
aberrant repair events. Intriguingly, 4 of the 7 Rag1S723C/S723Cp53−/− lymphomas contained 
translocations and short-arm fusions that involve the chromosomes lacking rearranging TCR 
loci.  
Similarly, the Art-P70 mutation in a p53 null background accelerates the timing of tumor onset 
compared with p53 mutation alone. Art-P70/p53 double mutant mice predominantly succumb 
to CD4+CD8+TCRβ− thymic lymphomas that are associated with clonal chromosomal 
translocations involving the TCR or IgH loci; however, the majority of tumors do not harbor the 
hallmark gene amplification events observed in NHEJ/p53 double null lymphomas, including 
those arising in Art−/−p53−/− mice [186, 233, 234]. We found that the ArtP70/P70p53−/− and 
Art−/−p53−/− lymphomas arise with a similar latency, despite our observation of substantially 
higher levels of aberrant interchromosomal rearrangements in Art-P70 mutant lymphocytes. 
One potential explanation for these observations is that the timing of lymphoma incidence is 
influenced by the particular oncogenic events associated with tumorigenesis. In this regard, 
genomic amplification leading to elevated expression of c-myc or N-myc in Art−/−p53−/− 
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lymphomas may lead to a higher proliferative potential compared with oncogenic events in the 
ArtP70/P70p53−/− background, thereby accelerating tumorigenesis in Art/p53 double null mice.  
The frequently arising ArtP70/P70p53−/− thymic lymphomas are associated with clonal 
translocations involving chr. 6, 12, 13 and 14 which harbor the murine TCRβ, IgH, TCRγ and 
TCRα/δ loci, respectively, with chr. 14 translocations observed in the majority of the tumors 
analyzed. Cytogenetic analyses of activated T cells isolated from human lymphoma patients 
harboring the hypomorphic allele modeled in the Art-P70 mouse and a similar C-terminal 
truncating mutation (T432SfsX16) revealed a translocation of chr. 7 and 14 and inversion of chr. 
7, respectively [147]. In humans, the rearranging IgH and TCRα/δ loci reside on chr. 14, whereas 
TCRγ and TCRβ reside on chr. 7. Thus, Art-P70 hypomorphic allele results in translocations 
involving chromosomes that undergo V(D)J recombination in both human and murine 
lymphocytes.  
Potential oncogenic mechanisms. 
After our RAG1-S723C mouse study was published, Deriano et al. reported that mice expressing 
core RAG2 (cRAG2) that lacks C-terminal region also exhibit aberrant V(D)J rearrangements 
(translocations and hybrid joins at the antigen receptor loci) and, on a p53-mutant background, 
develop thymic lymphomas [65].  We propose the following explanations to account for the 
observed tumorigenesis.  
1. RAG1-S723C mutant may predisopose to errors in substrate recognition.  
Our observations that majority of the Rag1S723C/S723Cp53−/− lymphomas contained 
rearrangements that involve the chromosomes lacking rearranging TCR loci raise the intriguing 
possibility that the S723C mutant alters or loosens the cleavage specificity of the RAG1/2 
endonuclease. The S723 residue resides within a central domain of RAG1 (amino acids 528-760 
of 1040) that binds with sequence specificity to RSSs [241].  Biochemical studies of purified 
RAG1-S723C indicate that this amino acid is important for proper interactions with flanking 
coding region DNA during both precleavage and postcleavage events [199]. Thus, perturbations 
in specific contacts between RAG1/2 and the recombining DNA may alter cleavage activity.  
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What are the potential consequences of aberrant DNA cleavage by a dysfunctional RAG1/2 
endonuclease? Cleavage of cryptic RSSs or non-B conformation DNA structures by RAG1/2 has 
been hypothesized as one mechanism by which oncogenic chromosomal translocations arise in 
some human lymphoid malignancies [178, 179]. In addition, unbiased scans of human and 
murine genomes revealed cryptic RSSs that can be efficiently cleaved by RAG1/2, [242, 243] 
indicating that abundant cleavage sites outside of the antigen receptor loci exist in mammalian 
genomes. A mutant RAG1/2 endonuclease with altered or loosened cleavage specificity could 
more frequently generate DNA breaks at the numerous cryptic RSS sequences or non-B form 
structures present in the genome. Thus, we speculate that the S723C mutation may permit 
more frequent endonucleolytic cleavage of cryptic RSSs or non-B form DNA structures within 
the genome, thereby generating substrates for aberrant DSB repair events, including 
chromosomal translocations. 
2. End-joining errors- destabilization of post-cleavage complex. 
RAG proteins may form a scaffold to hold the cleaved DNA ends. RAG1-S723C mutation results 
in premature release of DNA ends from post-cleavage complexes in vitro. Premature release of 
V(D)J ends in developing lymphocytes would result in accumulation of unprotected, unrepaired 
DSBs which can engage in chromosomal translocations. Failure to detect loss of DNA ends by 
inversional recombination analysis does not entirely preclude this hypothesis. Reduced hybrid 
join formation was also observed in vitro by Tsai et al. [180], and an underlying catalytic defect 
might account for the lack of hybrid join formation. 
The Art-P70 mutation, which truncates the non-conserved C-terminus, results in elevated levels 
of V(D)J transrearrangements between loci located on different chromosomes and deletional 
hybrid joining in homozygous and heterozygous mutant lymphocytes. In comparison, 
undetectable or substantially lower levels of these chromosomal anomalies are present in 
Artemis null lymphocytes, thereby indicating that loss of functional regions within the C-




Previously, our lab has demonstrated that a mutant Artemis protein modeled after the P70 
allele, Art-D451X, interacted stably with DNA-PKcs and exhibited reduced DNA-PKcs-dependent 
endonucleolytic activity [82]. In addition, we found that loss of the C-terminal 241 amino acids 
markedly reduced DNA-PKcs-dependent phosphorylation due to deletion of the majority of 
phosphorylation sites. We hypothesized that these defects may impair the ability of Artemis to 
associate with and properly act upon DNA ends. Consistent with this notion, hairpin coding 
ends accumulate in ArtP70/P70 developing lymphocytes, whereas nicked hairpins with blunt or 5′ 
or 3′ overhanging ends are not detected [82]. In the current study, we observed increased 
levels of interchromosomal V(D)J rearrangements and deletional hybrid joints within the IgLκ 
and TCRβ loci in ArtP70/P70 primary lymphocytes.  
The mechanism underlying these events presumably involves inappropriate release of RAG-
generated DNA ends from post-cleavage complexes prior to joining [118, 128, 166]. In contrast, 
these aberrant rearrangements occur infrequently in Artemis null lymphocytes [244], despite 
harboring significantly higher levels of hairpin coding ends compared with Art-P70 mutant 
lymphocytes [82]. Although open hairpins are not detected in ArtP70/P70 lymphocytes, it is 
possible that a low level of nicked coding ends is present, and these end structures may be 
more likely to engage in aberrant events. However, interchromosomal rearrangements and 
deletional hybrid joining occur infrequently in wild-type lymphocytes in which hairpins are 
efficiently cleaved by Artemis. Likewise, coding ends in normal lymphocytes rarely serve as 
substrates for oncogenic translocations, even in a p53-deficient background which permits 
RAG-generated ends to persist throughout the cell cycle [171, 172, 200, 229, 234-238]. Thus, 
the Art-P70 allele likely causes molecular defects in coding end processing and joining beyond 
impaired hairpin nicking.  
Mutations in Atm, Mre11 or Nbs1 significantly increase the frequency of aberrant chromosomal 
rearrangements in mutant lymphocytes, including interchromosomal transrearrangements and 
deletional hybrid joint formation [118, 128, 166, 167, 170, 220, 221, 224, 225]. These 
observations led to the hypothesis that the ATM kinase and MRN complex function during V(D)J 
recombination to enhance DNA end complex stability and promote proper joining of RAG-
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generated breaks [118, 128, 166]. Our findings suggest that truncation of the C-terminus 
impairs functions of Artemis within post-cleavage DNA end complexes, thereby leading to 
inappropriate release and altered handling of V(D)J recombination intermediates. It is of 
interest to note that ATM phosphorylates Artemis at residues S503, S516 and S645 which are 
located within the C-terminal region that is deleted in the Art-P70 mutant protein [17]. ATM 
does not play a direct role in V(D)J recombination per se as ATM-deficient cells exhibit wild-type 
levels of V(D)J recombination on extra-chromosomal plasmid substrates [245]. However, ATM 
deficiency in mice leads to accumulation of V(D)J coding end intermediates, impaired 
lymphocyte development and aberrant, potentially oncogenic, chromosomal rearrangements 
[167, 169, 246-248]. Although ATM-dependent phosphorylation of Artemis is not required to 
activate intrinsic endonucleolytic activity in vitro nor is it required for V(D)J recombination on 
model plasmid substrates in cells [17], our findings raise the possibility that ATM 
phosphorylation may modulate Artemis functions during chromosomal V(D)J rearrangements 
to facilitate the stabilization of DNA end complexes in vivo.  
We propose that the Art-P70 mutant protein is recruited to DNA ends via interaction with DNA-
PKcs [82], and activation of DNA-PKcs upon autophosphorylation induces large conformational 
changes to allow the nuclease access to the hairpins [16, 17, 249]. Truncation of the Artemis C-
terminal region that contains ATM and DNA-PKcs phosphorylation sites may prevent stable 
association within conformationally altered DNA end complexes that are poised for further end 
processing events. Inappropriate release of the RAG-generated ends from aborted post-
cleavage complexes would render the ends more susceptible to misrepair, thereby increasing 
their potential to generate chromosomal aberrations, including oncogenic translocations [118].  
The precise mechanisms underlying the distinct molecular events observed in Art-P70/p53 
lymphomas have not yet been elucidated. Inactivation of the p53-dependent cell-cycle 
checkpoint has been hypothesized to allow unrepaired RAG-induced DNA ends generated 
during G1 to persist throughout the cell cycle and undergo mis-repair by alternative DSB repair 
pathways [186, 229, 233]. We speculate that unjoined coding ends in Art-P70 versus Artemis 
null lymphocytes may be repaired by distinct pathways that function during different cell-cycle 
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phases. Consistent with this notion, the junctional sequences of both intra- and 
interchromosomal V(D)J rearrangements in ArtP70/P70 lymphocytes are characteristic of joining 
mediated by the classical NHEJ pathway [82]. In comparison, an alternative pathway generates 
aberrant V(D)J junctions containing large deletions and long P nucleotide additions in Art−/− 
lymphocytes [158] and microhomology mediated translocations in Art−/−p53−/− lymphomas 
[234]. An alternative, though not mutually exclusive, hypothesis is that defects in DNA end 
complex stability in Art-P70 mutant lymphocytes allow unrepaired breaks to be aberrantly 
localized in three-dimensional space and engage in translocations that do not require the 
chromosomal partner to be located in proximity. In this regard, recent studies have provided 
evidence that loci involved in recurrent oncogenic translocations are located in proximity in 
lymphocytes [110, 250-252]. This hypothesis does not preclude amplification from occurring in 
the Art-P70 background, and indeed we did observe N-myc amplification in one ArtP70/P70p53−/− 
pro-B lymphoma (C263). It will be of significant interest to further define the molecular 
mechanisms underlying the oncogenic translocations in Art-P70/p53 tumors.  
In summary, these studies provide insight into the consequence of truncation of the Artemis C-
terminal domain and dysfunctional RAG1 activity on the fate of chromosomal DNA ends during 
endogenous V(D)J rearrangements. Aberrant DNA ends generated by substrate selection error 
and/or destabilization of end bound complexes possess significant potential to engage 
spontaneously in oncogenic chromosomal translocations. Together, these findings have 
important implications for tumor predisposition associated with hypomorphic mutations in the 
RAG or Artemis genes in the human population. 
2.5 Materials and Methods 
Mice. 
Gene-targeted ATM null, RAG1-S723C, RAG2 null, Artemis null and Art-P70 mice (mixed 
129Svev/C57Bl6 genetic background) were previously generated [82, 158, 253, 254]. p53 
mutant mice (Trp53tm1Tyj) in a 129S2/Sv background were obtained from Jackson Laboratory 
and bred with Rag1S723C/S723C, Art−/− and ArtP70/P70 animals. Double heterozygous Art+/−p53+/− and 
Art+/P70p53+/− mice were subsequently interbred to generate progeny of the desired genotypes 
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for the tumorigenesis studies (i.e. Art+/+p53+/+, Art−/−p53+/+, Art−/−p53−/− ArtP70/P70p53+/+, 
ArtP70/P70p53−/− and Art+/+p53−/−). The single- and double-mutant mice as well as wild-type 
controls used in the Art-P70 study were approximately 75% 129Sv and 25% C57Bl6; thus, the 
experimental cohorts are closely strain matched. Approval for use of animals in this study was 
granted by the University of Michigan UCUCA office (protocol number 08758). These mice were 
housed in a pathogen-free facility dedicated to immunocompromised animals. 
Interchromosomal V(D)J rearrangements 
Nested PCR amplification reactions used to detect TCRγ intrachromosomal and TCRγ-to-TCRβ 
interchromosomal transrearrangements were modified from methods as described previously 
[222]. Genomic DNA (100 ng) obtained from thymocytes isolated from 4- to 5-week-old mice 
[Art+/+ (n= 3), Art−/− (n= 7), ArtP70/P70 (n= 5), Art+/P70 (n= 10)] was amplified in 50 µl of reaction 
mixture containing set ‘a’ primers (10 pmol. The cycling conditions were: denaturation at 95°C, 
30 cycles of amplification at 95°C for 15 s, 55°C for 15 s, 72°C for 30 s with a 6-s increment per 
cycle followed by 10 min elongation at 72°C. The products from the first reaction (5 µl) were 
used in a nested PCR reaction with the same conditions using primers set ‘b’. The final PCR 
products (25 µl) were run on a 1.5% agarose gel followed by Southern blotting using probes 
(primers set ‘c’) internal to the primers used for PCR amplification. The second-round PCR 
products were subcloned into pCR 2.1-TOPO (Invitrogen; Carlsbad, CA, USA) and individual 
clones were sequenced. TCRβ Dβ2-to-Jβ2 intrachromosomal rearrangements were PCR 
amplified from thymic genomic DNA (100 ng) at an annealing temperature of 62°C (35 cycles). 
Each experiment was repeated at least thrice independently.  
Hybrid join analysis 
To analyze the levels of coding and hybrid joints between Vκ6–23 and Jκ1, PCR assays were 
used as described previously [128]. Genomic DNA (0.5 µg) isolated from mouse splenocytes for 
each genotype (ArtP70/P70; n= 4) was PCR amplified in 50 µl with 15 pmol of each primer. PCR 
conditions were as follows: 95°C for 5 min followed by 17 cycles of 94°C (30 s), 64°C (30 s), 72°C 
(30 s). A second PCR reaction was carried out under the same conditions for 25 amplification 
cycles using 4-fold dilutions of the first PCR reaction and nested primer pairs. The HJ and CJ PCR 
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products were transferred to Zetaprobe membrane and hybridized with pκg oligonucleotide. 
For normalization, 4-fold dilutions starting with 0.5 µg of genomic DNA were PCR amplified. For 
Vβ14 coding and hybrid joint analysis, genomic DNA (0.5 µg) was isolated from mouse 
thymocytes for each genotype [ArtP70/P70 (n= 2), Art+/P70 (n= 5)], and PCR analysis was performed 
as described [128]. The PCR products were analyzed by Southern blotting using the pβg 
oligonucleotide as a probe.  
Characterization of tumors 
Lymphoid tumors were analyzed by flow cytometry with antibodies against surface B-cell 
(CD43, B220, IgM) and T-cell (CD4, CD8, CD3, TCRβ, CD44, CD25) markers. Solid tumors were 
fixed in Bouin solution, paraffin embedded, and analyzed histologically by hematoxylin and 
eosin staining of sections. Thymic and pro-B lymphomas were cultured in RPMI medium 1640 
supplemented with 15% fetal calf serum, 25 U/ml IL-2 (BD Biosciences) and 25 ng/ml of IL-7 
(PeproTech, Rocky Hill, NJ, USA). The proportion of pro-B and thymic lymphomas in the 
ArtP70/P70p53−/− cohort was calculated to be statistically significantly different from that 
observed for Art−/−p53−/− lymphomas (P = 0.014, two-tailed Fisher's exact test). Data for 
Art−/−p53−/− tumors also in a mixed 129Sv/C57Bl6 genetic background from a previous 
publication [234] were included in the calculation (total of 13 lymphomas: 10 pro-B and 3 
thymic.)  
Chromosomal analyses of tumor metaphases 
Spectral karyotyping was performed either on metaphases from cells derived from the primary 
tumor (tumors 135, S542) or early passage tumor cells cultured as previously described [234] 
(all other tumors). SKY was performed using an interferometer (Applied Spectral Imaging; Vista, 
CA, USA) and SkyView software. Structural aberrations were considered clonal if present in 2 or 
more metaphases [172, 255]. For FISH analyses, early passage tumor cultures were exposed to 
100 ng/ml Colcemid for 5.5 h. BAC probes for FISH analysis were obtained from the RPCI-23 
library (Children's Hospital Oakland Research Institute; Oakland, CA, USA) and nick-translated 
using biotin-11-dUTP or digoxigenin-16-dUTP by standard procedures (Roche; Basel, 
Switzerland). BAC probes hybridizing to TCRα/δ are as follows: RPCI-23 204N18 (centromeric to 
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TCRα/δ region) and RPCI-23 269E2 (telomeric to TCRα/δ region). BAC probe hybridizing to TCRβ 
are as follows: RPCI-23 216J19 (spans TRBD1–TRBV31). BAC probe hybridizing to TCRγ are as 
follows: RPCI-23 212N5 (within TCRγ). BAC probes hybridizing to IgH are as follows: N-myc BAC 
A-10-1 [234], Bac199 (hybridizes to Cα), Bac 207 (hybridizes to V region). c-myc BAC probe was 
previously described [256]. At least 10 metaphases for each tumor were analyzed by SKY and at 
least 20 metaphases by FISH.  
Southern blot and RT-PCR analyses 
Genomic DNA (20 µg) isolated from control tissues (tail or kidney) or tumor masses was 
digested with EcoRI. Southern blotting was performed with previously characterized probes 
hybridizing within the TCRβ locus (Drd1), JH region, HS3a, Cµ, N-myc and c-myc loci. Southern 
blots were visualized using a Phosphorimager. Band intensities were quantitated using Image 
Quant TL v2005 software, and relative levels were normalized to a non-lymphoid locus (LR8). 
Fold amplification was calculated compared with the intensities of bands in the kidney controls 
on the same membrane.  
Reverse transcription of total RNA (1 µg) isolated from primary ArtP70/P70p53−/− (C219, C263) and 
Art−/−p53−/− (C405) pro-B lymphomas and wild-type LN was performed using a poly-dT [208] 
primer and MLV-reverse transcriptase (Invitrogen). PCR amplification of cDNAs was performed 
using gene-specific primers to c-myc (exons 1 and 3) and N-myc (exons 2 and 3). cDNA levels 
were normalized to tubulin. Bands were quantitated using AlphaImager 2200 (AlphaInnotech; 
Santa Clara, CA, USA). RT-PCR reactions were repeated at least four times. 
Acknowledgements 
This work was previously published in two separate publications: 
Giblin W, Chatterji M, Westfield G, Masud T, Theisen B, Cheng H, DeVido J, Alt F, Ferguson D, 
Schatz D, Sekiguchi J. Leaky severe combined immunodeficiency and aberrant DNA 




Jacobs C*, Huang Y*, Masud T*, Lu W, Westfield G, Giblin W, Sekiguchi JM. (2010) A 
hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and 
tumorigenesis. Hum Mol Genet. 2011 Feb 15. PMID: 21147755 
In this chapter, I have reproduced parts of both manuscripts with some modifications. We 
thank all the authors for their contribution to the study and manuscript. For the RAG1-S723C 
study, W.G. and M.C. performed experiments and analyzed the results; G.W., B.T., H.-L.C. and I 
performed experiments; J.D. generated vital reagents in the laboratory of F.W.A.; D.G.S., D.O.F., 
and J.S. conceptualized and designed experiments and interpreted the results; J.S. wrote the 
paper; and all authors read and edited the paper. For Art-P70 study, we thank Drs. David 
Ferguson and John Moran for helpful discussions. C.J., Y.H. and I contributed equally to the 
authorship*. Y.H. analyzed the tumors. Southern blot and FISH analyses were done by C.J. W.L., 
G.W. and W.G. performed experiments not mentioned in this chapter.  
Funding 
RAG1-S723C mice study was supported in part by the National Institutes of Health (NIH, 
Bethesda, MD) through the University of Michigan’s Cancer Center Support Grant (5 P30 
CA46592); NIH grant AI063058 (NIAID), Pew Scholars Award (Pew Charitable Trusts, San 
Francisco, CA), Munn IDEA award (UM Cancer Center, Ann Arbor MI) to JoAnn Sekiguchi.; NIH 
grant A132524 (NIAID) to D.G.S.; and NIH grant A135714 (NIAID) to FWA. TM is  a Fulbright 
Scholar. D.G.S. and F.W.A. are Investigators of the Howard Hughes Medical Institute. Art-P70 
study was supported by NIH grant AI063058 (NIAID), Pew Scholar’s Award (Pew Charitable 
Trusts), Munn IDEA award (UM Cancer Center) to J.M.S. and by the NIH UM Cancer Center 
Support Grant (5 P30 CA46592). C.J. received support from the NIH Genetics Training grant T32-
GM07544 (NIGMS), T.M. is a Fulbright Scholar and W.L. received support from the Cellular and 






Inhibition of ATM Kinase Activity Suppresses Ionizing Radiation-Induced Genomic Instability 
in Artemis-Deficient Lymphocytes  
 
3.1 Abstract 
The endonucleolytic activity of Artemis, an important canonical non-homologous end 
joining (C-NHEJ) factor, is required to process complex DNA double strand breaks post-
irradiation. It is also essential to open the hairpin coding ends that are formed during V(D)J 
recombination, a process necessary for antigen receptor gene assembly and lymphocyte 
development. Artemis deficiency results in cellular radiosensitivity and immunodeficiency with 
accumulation of hairpin coding ends in lymphocytes. Low level end-joining occurs in these cells 
and is characterized by extensive deletions, microhomologies and long stretches of P 
nucleotides indicating the presence of error-prone alternative end-joining (A-EJ) factors. The 
mechanisms that regulate these factors and the contribution of the DNA damage response in 
activating this pathway are poorly defined. In this study, we report that low dose ionizing 
radiation (IR) induces limited lymphocyte development and robust V(D)J rearrangements 
including aberrant trans-rearrangements in the Artemis-deficient mice and v-abelson 
transformed pre-B cell lines. These rearrangements have complex breakpoint junctions. The IR-
induced response is not observed in mice with both Artemis and ATM deficiency. Additionally, 
inhibition of ATM kinase activity in Artemis-null v-abl pre-B cells suppresses the formation of 
both coding joins and trans-rearrangements. Our data demonstrate that, in the developing 
lymphocytes, induction of ATM kinase activity can trigger an error-prone end-joining response 
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in the absence of Artemis leading to increased levels of genomic instability. This study 
offers useful insight into the mechanisms that regulate alternative end joining in lymphocytes 
and has important implications for cancer therapeutics.  
3.2 Introduction 
Genomic lesions such as chromosomal translocations, deletions and inversions are rare 
but serious outcomes of aberrant DNA double strand break (DSB) repair, and can lead to 
oncogenic transformation. DSBs result from exposure to cytotoxic agents (e.g., ionizing 
radiation and radiomimetic drugs) or arise as programmed intermediates during meiosis and 
lymphocyte-specific processes such as V(D)J recombination and class switch recombination 
[102].  
V(D)J recombination is a series of DNA rearrangements that is responsible for 
generating the genes that encode the vastly diverse variable regions of the T cell receptors 
(TCR) and B cell immunoglobulins (Ig) for antigen binding. These variable region exons are 
assembled from an array of variable (V), diversity (D) and joining (J) genomic segments [2]. This 
process is initiated by a lymphocyte-specific, G1-restricted RAG1/2 endonuclease that binds the 
recombination signal sequences (RSSs) flanking individual V, D and J segments [5, 257]. 
Cleavage by RAG1/2 generates two covalently closed hairpin coding ends and two blunt signal 
ends which are held together by the RAG proteins in a postcleavage complex [33, 35, 258]. The 
coding ends are subsequently processed and joined by the canonical non-homologous end-
joining (C-NHEJ) pathway.  
C-NHEJ, a major DNA DSB repair pathway, does not need a homologous sister chromatid 
to restore genomic integrity. It is initiated by the recognition of the DNA ends by Ku70/80 
heterodimer which then recruits DNA-dependent protein kinase catalytic subunit (DNA-PKcs), a 
serine/threonine protein kinase [111]. The RAG-induced breaks and a subset of general DSBs 
are subsequently processed by nucleases and polymerases [107]. Artemis (DCLRE1C, DNA 
Crosslink Repair 1C) gene encodes a nuclear protein which, in complex with DNA-PKcs, 
nucleolytically opens the hairpins at or near the apex with the addition of a few palindromic (P) 
nucleotides at the junctions [80]. Coding end processing is associated with loss of nucleotides as 
61 
 
well as de novo addition of non-templated N region nucleotides providing further junctional 
diversity [19, 20]. The processed DNA ends are then joined by DNA Ligase IV, XRCC4 and XLF to 
form a functional coding joint or V(D)J exon [13, 14, 259]. The RSS ends are directly joined 
without any processing to form a precise signal joint. DNA-PKcs and Artemis are largely 
dispensable for signal joint formation but are essential for coding end hairpin opening and 
processing. Since antigen receptor assembly is required for lymphocytes to develop, defects in 
V(D)J recombination due to mutations in RAG proteins or C-NHEJ factors lead to 
immunodeficiency disorders characterized by arrested B and T lymphocyte development. 
Artemis mutations are responsible for a subset of Severe Combined Immunodeficiency 
disorders with radiosensitivity (RS-SCID) which results from impaired repair of complex general 
DSBs. Some Artemis-deficient mice, however, have leaky T cell development [158]. 
Since DSBs are essential intermediates for V(D)J recombination, proper end joining is 
crucial to maintain chromosomal integrity in the developing and rapidly proliferating 
lymphocytes. Joining of the RAG-induced breaks by C-NHEJ pathway is regulated at many levels 
to avoid mis-joining particularly translocations [185, 198]. Rarely, due to an error in the V(D)J 
process, a proto-oncogene can be placed under the control of an Ig or TCR promoter region 
(e.g., immunoglobulin heavy chain IgH and c-myc translocations) leading to dysregulated cell 
growth, cell survial and malignant transformation. A majority of human progenitor and mature 
B-cell lymphomas and leukemias harbor recurrent clonal translocations involving RAG-induced 
breaks suggesting a role of aberrant end-joining in tumor initiation [109, 184, 260]. These 
tumor-associated translocations contain regions of microhomology at the junctions; thus, it has 
been hypothesized that alternative mechanisms of end-joining (A-EJ), which are frequently 
mediated by microhomologies may catalyze these events. Further evidence for the oncogenic 
role of A-EJ is provided by mice doubly deficient in C-NHEJ proteins (DNA-PKcs, Ku70, Ku80, 
Artemis, Ligase 4, XRCC4) and tumor suppressor, p53. These mice develop progenitor-B cell 
lymphomas harboring aberrant rearrangements involving the RAG-induced breaks 
[der(12)t(12;15) translocations and IgH/c-myc  or IgH/N-myc coamplifications] [238, 240, 261]. 
The pro-B lymphomas that arise in Artemis/p53-null mice lack der(12)t(12;15) translocations 
and IgH/c-myc amplification [261]. Instead, they contain IgH/N-myc coamplifications.  These 
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studies reveal the tumor suppressor functions of C-NHEJ factors and potential contribution of 
translocation-prone A-EJ mechanisms in lymphomageneis. However, the details of end-joining 
factors and mechanisms responsible for these events are still largely unknown.  
Several studies over the last two decades have indirectly provided evidence for the 
existence of an A-EJ mechanism in the lymphocytes. C-NHEJ deficient mice are unable to join 
RAG-induced breaks and accumulate unresolved coding ends in their developing lymphocytes. 
Exposure of SCID mice with mutant DNA-PKcs to agents that induce DNA DSBS such as whole 
body gamma(γ) irradiation promotes the repair of preexisting unrepaired hairpins and induces 
rearrangements at TCR loci (TCR-β, δ, γ) in progenitor T lymphocytes [262, 263]. These V(D)J 
rearrangements are associated with a limited maturation of double negative (DN) progenitor T 
lymphocytes- characterized by the lack of expression of CD4 and CD8 cell surface  receptors- to 
CD4+CD8+ double positive (DP) cells. RAG-null thymocytes that do not contain cleaved coding 
ends also progress to DP stage on exposure to γ-irradiation; they bypass β-selection indicating 
that development can occur through TCRβ chain-independent processes [264, 265]. Studies 
using extrachromosomal substrates in pre-B cells led to the hypothesis that γ-irradiation 
impacts V(D)J recombination directly, independent of the thymic stromal influences [266] 
leading to interesting speculations about the role of ionizing radiation (IR) in inducing end-
joining in lymphocytes. However, the factors that regulate this response are still mostly 
unexplored. In addition, the contribution of Artemis and/or other nucleases in this response is 
also undefined. Thus, these mice are a valuable in vivo model system to further elucidate the 
role of various factors involved in IR-induced lymphocyte development and V(D)J 
rearrangements.  
In addition to the C-NHEJ factors, other proteins of central importance in DSB repair play 
roles in facilitating efficient joining of RAG-induced breaks. DNA DSBs, including those induced 
by IR, are sensed by the MRE11/RAD50/NBS1 (MRN) complex which then activates ATM-
dependent DNA damage response [267]. Ataxia telangiectasia mutated (ATM), a member of  
phosphatidylinositol 3-kinase-like kinase (PIKK) family, phosphorylates several substrates for 
cell cycle arrest and efficient DNA repair, and  ATM mutations result in marked radiosensitivity 
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[268]. Although it is dispensable for the repair of RAG-induced breaks, ATM deficiency is also 
associated with mild to moderate immunodeficiency and predisposition to lymphomas 
associated with antigen receptor translocations [167, 269]. More recently, the immune 
phenotype was attributed to its role in regulating the stability of RAG-induced DNA ends in 
post-cleavage complexes [128]. ATM can be activated by RAG-induced DSBs and modulates 
transcriptional program important for normal lymphocyte development in the absence of 
Artemis [244, 270, 271]. IR-induced V(D)J rearrangements in C-NHEJ deficient mice suggest that 
DNA damage response (DDR) might also contribute to the activation of error-prone end-joining 
mechanisms. However, the exact role of ATM-dependent DNA damage response (DDR) in 
promoting aberrant V(D)J recombination still needs to be investigated.  
In the current study, we examined the effect of low-dose IR on lymphocyte 
development and V(D)J rearrangements in Artemis-deficient mice T lymphocytes and  Abelson 
transformed murine pre-B cell lines. We demonstrate that IR induces robust intra- and inter-
locus end joining in these cells. Further, inhibition of ATM kinase activity suppresses the 
formation of these coding joins and translocations. Our study provides insight into the role of 
ATM-dependent DNA damage response in mediating chromosomal translocations in the 
lymphocytes. It also has implications for therapy-induced translocations and therapeutic 
interventions.  
3.3 Results 
T lymphocyte differentiation is induced in Artemis deficient mice by low-dose γ-irradiation.  
Productive TCRβ gene rearrangement and subsequent surface expression of pre-TCR 
(comprising of TCRβ and pre-Tα chains, and CD3) allows CD4-CD8- (DN) T lymphocytes to 
proliferate and advance to the CD4+CD8+ (DP) stage of development [89]. In the absence of 
Artemis endonuclease activity, hairpin coding ends fail to undergo rearrangements and the 
majority of T lymphocytes are arrested at the DN stage. To determine if low dose γ-irradiation 
leads to an induction of T lymphocyte differentiation in Artemis deficiency, 2.5 Gy of whole-
body γ-irradiation was administered to 3 to 5-week-old Artemis null (Art-/-) mice in a single 
dose. Three weeks later, thymocytes were examined for CD4, CD8 and TCRβ expression by flow 
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cytometry. Representative profiles of un-irradiated and irradiated wild-type (WT) and Art-/- 
thymocytes are shown in figure 3.1A and supplementary figure S3.1. As anticipated, a 
significantly lower percentage of DP and surface TCRβ positive (sTCRβ+) thymocytes were 
detectable in the thymi of the unirradiated Art-/- mice as compared to the WT mice (Figure 3.1B, 
3.1C, Table 3.1). Upon irradiation, the WT mice did not exhibit significant changes in the mean 
percentages of thymocyte population from the control WT mice (Figure 3.1B, 3.1C; Figure S3.1).  
In contrast, we observed an over 870-fold increase in the percentage of DP thymocytes in Art-/- 
mice after irradiation (Figure 3.1C, Table 3.1). The percentage of sTCRβ+ thymocytes was also 
significantly increased by 3.5-fold after irradiation. Next, the intracellular expression of TCRβ 
(icTCRβ) was examined. The increase in icTCRβ+ cells was striking with a 28-fold increase in the 
irradiated Art-/- mice as compared to the unirradiated mice of the same genotype (Figure 3.1D, 
Table 3.1). This indicates that productive in-frame TCRβ rearrangements were induced by low-
dose IR even in the absence of Artemis. The progression in development stage in these mice 
was not accompanied by a large increase in thymic cellularity (Table 3.1). We also failed to see 
an increase in distinct CD4+ or CD8+ single positive T-cell population in thymus or in the 
peripheral lymphoid tissues (spleen and lymph nodes) of the irradiated Art-/- mice (data not 
shown). A functional TCR comprised of TCRβ and TCRα chains is required for the transition of 
DP cells to mature single positive cells. Lack of peripheral CD4+ or CD8+ single positive cells in 
the irradiated Art-/- mice suggests that despite a significant increase in intracellular TCRβ, a 
functional TCR is not be formed in these cells.  
 
Table 3.1: Impact of Ionizing Radiation on T Lymphocytes in Art-/- mice 
 
 
0 4 124.6 + 24.9 83.4 + 1.03 19.4 + 1.3 28.8 + 2.8
2.5 4 100.3 + 25 74.3 + 2.02 18.2 + 1.7 22.5 + 1.2
0 5 6 + 2.6 0.06 + 0.02 1.5 + 0.2 0.4 + 0.1
2.5 6 8.4 + 2.7 52.7 + 5.2 5.3 + 0.7 12.3 + 4.2
        
        
        
        
sTCRβ+ cells                 
(% of total)
Thymocyte 













To determine if IR induces Art-/- B lymphocyte differentiation, we examined the surface 
IgM expression in bone marrow cells and splenocytes by flow cytometry. In contrast to the 
induced development of thymocytes, γ-irradiation failed to simultaneously rescue B lymphocyte 
development in the Art-/- mice and cells were arrested at the immature B220+IgM-  pro-B stage 
(Figure 3.1E, data not shown), as has been shown previously for the DNA-PKcs mutant SCID 
mice [262, 272]. Thus, our data demonstrate that sublethal irradiation of Art-/- mice induces a T 
lymphocyte-specific developmental progression with readily detectable DP cells expressing 
surface and intracellular TCRβ. However, this is not associated with an increase in CD4+ or CD8+ 
SP cells. Likewise, we do not observe IR-induced developmental progression in B lymphocytes. 
Figure 3.1: Low-dose IR induces T lymphocyte development in Art-/- mice. 
 
Figure 3.1. 3 to 5-weeks-old WT and Art-/- mice were exposed to 2.5 Gy and analyzed 3 weeks 
later for lymphocyte development. (A) Flow cytometric analysis was done on thymocytes from 
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the unirradiated and the irradiated mice for cell surface CD4, CD8, TCRβ and intracellular CD4 
and TCRβ expression. (B, C, D) Graphs representing percentages of thymocytes expressing (B) 
cell surface CD4 and CD8, (C) surface TCRβ and (D) intracellular TCRβ. The bars represent 
means for each group with SEM. (E) Flow cytometric analysis was done on bone marrow cells 
from the unirradiated and the irradiated mice for B220+IgM+ B lymphocytes. 
Irradiated Art-/- mice exhibit rearrangements at the TCRβ locus.  
In the developing T lymphocytes, TCR Dβ-to-Jβ rearrangements occur at DN2 stage, 
followed by Vβ-to-DJβ rearrangements in DN3 cells. Detection of extra- and intracellular TCRβ 
in the irradiated Art-/- thymocytes led us to examine the status of V(D)J rearrangements at the 
TCRβ locus in response to γ-irradiation. The TCRβ locus consists of a cluster of V segments and 
two clusters of Dβ and Jβ segments, Dβ1 to Jβ1(1-6) and Dβ2 to Jβ2(1-7) (Figure 1.). Genomic 
DNA from individual thymi was analyzed by PCR and Southern blot analysis, using primers 
specific for Dβ1 to Jβ1 and Dβ2 to Jβ2. Figure 3.2A shows that there is no obvious difference in 
the levels of rearrangements between the unirradiated and the irradiated WT mice. Bands 
corresponding to rearranged Dβ1Jβ1 products were not detected in unirradiated Art-/- mice. In 
contrast, bands were readily detected in irradiated Art-/- mice to levels that are comparable to 
those seen within the WT thymus. Detection of multiple bands indicates polyclonal origin of 
TCRβ rearrangements. The same was observed for Dβ2Jβ2 rearrangements (data not shown). 
These results indicate that IR exposure of Art-/- mice not only promotes immature thymocyte 
differentiation, but also induces substantial TCR Dβ-to-Jβ rearrangements. Next, we examined 
Vβ10 to Jβ2 and Vβ12 to Jβ1 rearrangements by PCR analyses. Vβ-to-DJβ rearrangements were 
also detectable, albeit at lower levels, in the irradiated Art-/- mice as compared to the WT mice 
(Figure 3.2A, data not shown). This suggests that most of the rearranged D and J segments 
















Figure 3.2. (A) Thymic DNA was prepared from the unirradiated and irradiated WT and Art-/- 
mice and PCR analyses done to determine Dβ1 to Jβ1 and Vβ12 to Jβ1 rearrangements. A non-
lymphoid tissue (tail) was included as a negative control. DNA input was normalized using PCR 
for a non-rearranging gene. (B, C, D, E) PCR products for Dβ1 to Jβ1 rearrangements from two 
irradiated Art-/- mice were subcloned into the TOPO2.1 vector and sequenced. Plots 
representing the distributions of (C) deletion, (D) insertion, (E) P-nucleotide (P NT) and (F) 
microhomology (MH) lengths at the Dβ1 to Jβ1 breakpoint junctions are shown. The number of 
sequences (N) and median value for each experimental group is indicated below the graph. The 
horizontal bar represents the median value for each group. (B) Each value indicates combined 
deletion at both coding ends within a single junction. (C) Each value includes all the nucleotides 
inserted at the junction. (D) Each value represents P NT length at an individual coding end. (E) 
Each value indicates microhomology (MH) length at breakpoint junctions with no insertions. (F) 
All the sequence analyses were combined and segregated in to two groups. Pie charts 
representing the percentages for each group in the un-irradiated and irradiated WT and Art-/- 
mice are shown.  
 
Intrachromosomal Dβ1 to Jβ1 joins from irradiated Art-/- mice are processed in a different 
manner from those in unirradiated mice.  
Next, we sequenced the PCR products corresponding to Dβ1-to-Jβ1 rearrangements to 
get insight into the IR-induced mechanisms that facilitate the coding end joining. In the absence 
of Artemis, the defect in recombination is not absolute and rearrangements, albeit at lower 
levels, still occur. These coding joins are mostly structurally abnormal containing extensive 
deletions, microhomologies and long stretches of palindromic nucleotides (P NT) [214]. In 
contrast, when Artemis endonuclease activity and C-NHEJ are intact, the junctions are 
characterized by small deletions at the ends, short P and N nucleotide insertions, with rare use 
of microhomologies (Figure S3.7).  
Figures 3.2B-3.2G and S3.2 show distributions and structural comparisons of the joins 
isolated from the WT and Art-/- mice. The junctional sequences are shown in Figure S3.4A. We 
analyzed these sequences for end-modifications including deletions, P and N nucleotide 
insertions and use of microhomologies. For all our sequence analyses, each deletion value 
represents combined deletions at both ends for each individual join. As expected, most of the 
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WT joins, with or without IR, contained deletions of <10 bp (Figure S3.2). The median deletion 
lengths were also less than 10bp (Figure 3.2B). Over half of the junctions in the Art-/- cells 
exhibited deletions of >10 bp and a higher median deletion length of 13 bp (Figure 3.2B, Figure 
S3.2). In the irradiated Art-/- mice, the frequency of joins containing deletions longer than 10bp 
(39%; median deletion length, 5.5bp) was lower as compared to the un-irradiated cohort. 
Surprisingly, we observed a striking increase (39%) in joins with no deletions in the Art-/- 
lymphocytes upon irradiation (0% in WT and in un-irradiated Art-/- cells). 
The junctions were also different with regard to the length of nucleotide insertions 
(Figure 3.2C, Figure S3.2). We analyzed the total number of nucleotides added, including P NT 
(underlined sequences), in an individual join. In the WT and un-irradiated Art-/- mice, all the 
joins contained insertions of <10 bp with median insertion lengths of <4 bp. Upon irradiation of 
Art-/- mice, joins had more complex insertions. Approximately 22% of junctions had 11 to 22 bp 
long insertions with long stretches of non-P NT, although the median insertion length was only 
3 bp. To determine if the non-P NT were randomly added or derived from a distant flanking 
sequence, we used Blast anlaysis to align them with the mouse TCRβ locus. Figure S3.2B shows 
some of these sequence alignments. “ATATTTCCC” or “GATATTTC”, parts of an inserted 
sequence, could have been derived 10 kb or 0.6 kb upstream of Dβ1 segment, respectively and 
inserted within the junction. However, because of the short length of these sequences, it is 
hard to make a conclusive statement about the origin of these nucleotides.  
As for the P nucleotide length specifically, coding ends with no deletions were analyzed 
(Figure 3.2D, Figure S3.2A).   All such coding ends within junctions from the unirradiated WT 
mice and over 85% from the un-irradiated Art-/- mice were <4 bp long with median P NT lengths 
of 0 bp each. One out of nine coding ends in the irradiated WT mice had 9 bp long P NT with 
extensive resection at the J segment and a 5 bp long MH residing within that end and the P NT 
sequence derived from the other end (Figure S3.7). On the other hand, 25% of the coding ends 
in the irradiated Art-/- mice had 4-10 bp long P NT with median length of 2 bp. These data show 
that the lengths of nucleotide insertions and P NT are increased at the V(D)J joins recovered 
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from the irradiated Art-/- thymocytes and rarely in the irradiated WT cells. Moreover, some of 
these joins exhibit complex nucleotide insertions.  
For microhomologies (MH), joins with no insertions were analyzed.  WT joins showed no 
MH whereas 20% of Art-/- junctions showed MH of 1-4 bp, the median MH length being 0 bp in 
each case (Figure 3.2E, Figure S3.2A). In contrast, after irradiation, 80% of the respective Art-/- 
junctions showed 1-4 bp long MH with a median length of 2 bp. Our results may not accurately 
reflect the actual proportion of junctions with MHs as the sample size for this analysis was very 
small (<6 joins for each genotype). Nonetheless, our results indicate that MH are used for end-
joining in irradiated Art-/- mice.  
Finally, to get an overall estimate of the proportion of abnormalities, we pooled our 
results in to two categories (Figure 3.2F). Group I includes all the WT-like analyses with (1) 
Deletions ≤10 bp, (2) Insertions ≤10 bp, (3) P NT ≤3 bp and (4) no MH. Group II includes all the 
abnormal analyses with (1) Deletions ≤10 bp, (2) insertions >10 bp (3) P NT >3 bp and (4) MH ≥1 
bp. About 98% of the WT sequences are represented in Group I with only 2% in Group II. 22% of 
un-irradiated Art-/- and 33% of irradiated Art-/- sequences are, however, represented in Group II 
indicating an overall increase in aberrant joins in Art-/- mice which is further enhanced after IR. 
Altogether, our sequence analyses suggest that in the absence of Artemis, at least some 
chromosomal breaks are processed differently after IR.  
Aberrant interchromosomal trans-rearrangements at the antigen receptor loci in irradiated 
Art-/- thymocytes.  
To investigate if IR induces chromosomal translocations between RAG-induced breaks in 
Art-/- thymocytes, we examined aberrant interchromosomal trans-rearrangements between the 
TCRγ and TCRβ loci located on mouse chromosomes 13 and 6, respectively. TCR Vγ-to-Jγ and 
TCR Dβ-to-Jβ rearrangements are completed in DN2/DN3 cells [219]. We used a nested PCR 
method using primers flanking TCRγV and TCRβJ segments as shown in Figure 3.3A. The results 
were confirmed by Southern blot analysis. PCR products corresponding to translocations were 
not detected in the WT thymocytes (Figure 3.3B). In comparison, we detected elevated levels of 
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trans-rearrangements in Atm-/- thymocytes, as has been shown previously [220]. Surprisingly, 
low-dose IR (2.5 Gy) induced a substantial increase in interchromosomal rearrangements in the 
Art-/- mice. Detection of bands of different sizes indicated polyclonal origin of translocations. 
These data demonstrate that chromosomal breaks accumulating in Art-/- thymocytes can 
transition into chromosomal translocations after exposure to low dose γ-irradiation.   
Next, the PCR products corresponding to trans-rearrangements in the irradiated Art-/- 
mice were subcloned and sequenced to gain a better understanding of the underlying end-
joining mechanisms (Figure 3.3C, Figure S3.4B). The junctions were analyzed as described 
earlier. About 38% of the joins had deletions spanning more than 10 bp, 25% had insertions >10 
bp and 27% coding ends contained unusually long P NT (6-8 bp). This was similar to what we 
observed in Dβ1Jβ1 junctions from these mice (Figures 3.3C and S3.2). We identified only one 
junction out of five with MH of 5 bp in length. Pooling these analyses in group I or II (as 
described earlier) revealed that 29% of the total analyses were structurally abnormal. Thus, our 
results demonstrate that translocations are catalyzed, for the most part, in a manner similar to 
the intrachromosomal joins in the irradiated Art-/- thymocytes.  
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Figure 3.3:  Low-dose IR induces aberrant interchromosmal trans-rearrangements at the RAG-
induced breaks in Art-/- T lymphocytes. 
 
(A) Schematic of the interchromosomal trans-rearrangements between TCRγV and TCRβJ loci. 
(B) Nested PCR analyses were performed on thymic DNA isolated from the unirradiated and 
irradiated mice to determine TCRγV-βJ transrearrangements. DNA input was normalized using 
PCR for a non-rearranging gene. (C) PCR products corresponding to transrearrangements were 
subcloned in TOPO2.1 vector and sequence analysis was done. Table showing frequencies of 
the translocation junctions with deletions (0, 1-10, >10 bp), insertion (0, 1-10, >10 bp) and MH 




Coding joins are induced by IR in immortalized Art-/- pre-B cell lines.  
Since the process of V(D)J rearrangement is essentially similar in T and B lymphocytes, 
we reasoned that IR might trigger apoptosis in Art-/- progenitor B cells in vivo which may 
account for the lack of IR-induced development. To examine the effect of IR on V(D)J 
recombination in immortalized Art-/- B lineage cells in chromosomal context, we used (v)-Abl 
kinase-transformed mouse pre-B cell lines with Bcl2 transgene. The immunoglobulin light chain 
(IgL) locus has not undergone rearrangement in these cells. Treatment with Abelson kinase 
inhibitor, STI571 (gleevec), arrests the cells in G1 which is associated with RAG1/2 expression. 
This leads to rearrangements at the Igκ locus as well as a single copy retroviral recombination 
substrate (pMX-GFP-IRES-hCD4) or pMX-INV, which has been described previously [128]. 
Normal recombination in this substrate leads to the formation of coding join within the 
chromosome resulting in GFP expression which can be detected by flow cytometry (Figure 
3.4A).  
Upon RAG induction, Artemis deficiency is associated with accumulation of unrepaired 
coding ends in these cells [244]. We observed that arresting Art-/- cells (two clonal cell lines 
were used, c.30 and c. 4) in G1 induced an increase in the percentage of GFP+ cells; 8-13% GFP+ 
cells were detectable after G1-arrest for five days (Figure 3.4C).  To rescue the end-joining 
defect, we expressed full-length (FL) Artemis in the Art-/- c.30 cell line. In these cells, 
approximately 85% GFP+ cells were detectable five days after G1 arrest, which was comparable 
to what we observe in a control WT pre-B cell line, WT INV5. Next, to examine the effect of IR 
on V(D)J recombination, cells were irradiated at 5 Gy and analyzed 72 hours post-irradiation 
(Figure 3.4B). There was no significant difference in the number of GFP+ cells between the 
untreated (no STI571/no IR) and only IR-treated cells of either genotype. Similarly, upon 
irradiation, there was no increase in the percentage of GFP+ cells beyond what we observe in 
unirradiated G1-arrested WT cells (WT INV5 and Art-/-c.30+FL-Artemis) (Figure 3.4C; data not 
shown).  However, in both G1-arrested Art-/- cell lines, there was a slight but significant increase 
of 3-5% in GFP+ cells after IR. (Figure 3.4C). The cell survival was not affected by IR treatment of 
the G1-arrested cells (Figure S3.3).  
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Figure 3.4:  V(D)J rearrangements are induced upon irradiation in murine Abelson-
transformed Art-/- pre-B lymphocytes. 
 
Figure 3.4. (A) Schematic diagram of pMX-INV V(D)J recombination substrate in non-
rearranged, cleaved and rearranged forms. The RSS are shown in triangles. (B) v-abl pre-B 
lymphocytes are irradiated with 5 Gy 48 hours after being arrested in G1 by STI571. The cells 
are analyzed 72 hours after IR. (C) Graphs representing percentages of pre-B lymphocytes that 
are GFP positive 72 hours after IR. Percentages were determined by flow cytometry in the 
following cell lines: Art-/- c.30, Art-/- c.4 and Art-/-c.30 with full-length Artemis. The bars and 
error bars indicate means and SEM, respectively. P values were calculated using unpaired 
Student’s T test. The data are representative of at least three independent experiments. (D) 
Southern blot analyses for coding joins at the pMX-INV and Igκ loci. DNAs from pre-B 
lymphocytes were PCR amplified. The bands corresponding to coding joins are indicated. DNA 
input was normalized using PCR for a non-rearranging gene. The data are representative of at 




We next examined the formation of coding joins (CJ) at Igκ (Vκ6-23 to Jκ1) and pMX-INV 
loci 72-hours after irradiation by PCR and Southern blot analysis. CJ were robustly induced in 
G1-arrested WT cells, however there was no obvious difference in the levels of joins at these 
loci with or without IR (Figure 3.4D). In the G1-arrested Art-/- cells, CJ were detectable at both 
loci. However, upon irradiation of the G1-arrested cells, the levels were markedly higher at the 
Igκ locus in both Art-/- cell lines (Figure 3.4D). At the pMX-INV locus, CJ were also induced after 
STI571 treatment, but we did not observe a difference in the CJ levels (Figure 3.4D). This might 
result from excessive cycling driving the PCR to saturation. Nonetheless, altogether these 
results demonstrate that low level of V(D)J recombination occurs in Art-/- pre-B cells after G1-
arrest and this response is further enhanced by IR only in Artemis deficiency and not in the WT 
pre-B cells.  
Sequence analysis of coding joins at Igκ and pMX-INV loci.  
Next, we examined the junctional sequences of the CJ recovered from the G1-arrested 
WT INV5 and Art-/- cells, as described earlier for TCR rearrangements and in Figures 3.5, S3.5-
S3.9. The subsequent analysis represents combined sequences from Vκ6-23 to Jκ1 and pMX-
INV CJ recovered from each cohort. Altogether, in the WT cells less than 10% junctions analyzed 
were structurally abnormal (Group II) with or without IR (Figure 3.5A). In comparison, the 
percentage of abnormal joins that were included in Group II increased from 23% to 37% in Art-/- 
c.4 cells. In the Art-/- c.30 cells, the percentage of abnormal joins increased only by 3%. 
As for the specific modifications, the joins were prominently different in total 
nucleotides and P NT inserted at the junctions (Figure 3.5B). The percentage of joins containing 
>10 bp long insertions increased from 0% to 11% and 16% in Art-/- c.4 and c.30, respectively. 
Similarly, the frequency of coding ends containing >3 P NT within a junction increased by 29% 
and 15% in the two lines. In comparison, only one WT junction contained >3 PNT. No insertions 
longer than 10 bp were observed in the WT junctions. Extensive deletions spanning more than 
15 bp within a junction and microhomologies were utilized more frequently in the Art-/- cell 
lines as compared to the WT cells. However, no remarkable differences were observed 
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between the unirradiated and the irradiated groups. We also did not observe any remarkable 
difference in the median  
Figure 3.5: Sequence analysis of breakpoint junctions from Igκ and pMX-Inv coding joins 
 
 
Figure 3.5. PCR products corresponding to coding joins at the Igκ and pMX-INV loci were 
subcloned into pCR TOPO2.1 and sequenced. (A) The sequence analyses for both loci were 
combined for each cohort and then pooled into two groups. Pie charts showing the percentages 
for the two groups are depicted here for Art-/- c.4, Art-/- c.30 and WT-INV5 cells. (B, left panel) 
Plots representing the combined distributions of deletion, insertion, P NT and MH lengths at 
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breakpoint junctions of coding joins from both loci are shown. The number of sequences (N) 
and median value for each experimental group is indicated below the graph. The horizontal bar 
represents the median value for each group. The sequences were analyzed as described in 
Figure 3.2. (B, right panel) Pie charts representing the percentages of joins with normal and 
longer deletions, insertions, P NT and MH lengths at the coding joins from both loci are shown 
for the indicated genotype.  
 
lengths of deletions, insertions, P NT and MH. In sum, our analysis shows that IR not only 
induces V(D)J rearrangements in the G1-arrested pre-B cells but the joins are mostly catalyzed 
in the same manner as in vivo with long nucleotide insertion including palindromic nucleotides. 
IR induces translocations between V(D)J loci in Art-/- pre-B cells.  
To determine if mis-joining between V(D)J loci can occur in G1-arrested Art-/- pre-B cells 
after IR, we devised a PCR strategy to amplify trans-rearrangements between the Igκ and pMX-
INV loci (Figure 3.6A). The results were confirmed by Southern blot analysis. PCR products 
corresponding to trans-rearrangements were rarely detectable in G1-arrested WT INV5 cells 
after IR (Figure 3.6B). The rearrangement products were observed in the Art-/- c.4 cells only 
after combined STI571 and IR treatment in all the samples from four independent experiments. 
The trans-rearrangement products were detectable in 50% of the samples from the STI571-
treated Art-/- c.30 cells. We did not observe an increase in frequency in this cell line upon 
irradiation. These results suggest that trans-rearrangements can be observed infrequently in 
the WT pre-B cells after IR. These aberrant events can arise in Art-/- cells upon G1 arrest. 
However, the frequency of trans-rearrangements is increased after IR treatment of the G1-
arrested Art-/- cells. 
Next, we analyzed the junctional sequences of the trans-rearrangement products, as 
described earlier (Figure 3.6C). All junctions were structurally abnormal containing either >15 
bp long deletions or complex insertions. Some sequences appeared to have been templated (in 
red) from the Vκ6-23 flanking sequence. In addition multiple single nucleotide misalignments  
78 
 





Figure 3.6. (A) Schematic of PCR to analyze trans-rearrangement between pMX-INV and Igκ 
loci. (B) DNA was collected from pre-B lymphocytes 72 hours after IR and PCR analyses done to 
amplify the trans-rearrangement products. The PCR products were confirmed by Southern blot. 
DNA input was normalized using PCR for a non-rearranging gene (Top panel). The frequencies 
of trans-rearrangements are shown in the bottom panel (C) PCR products corresponding to 
transrearrangements were subcloned in TOPO2.1 vector and sequenced. The table in the top 
panel shows the frequencies of deletions, insertions, P NT insertions and MH length at the 
breakpoint junction. The bottom panel shows sfequences from two Art-/- lines. Coding end 
sequences are boxed above the rearrangements. P NT are underlined. N nucleotides are 
indicated between the coding segments. MH are represented in bold. Samples from at least 
three independent experiments for each cell line were used for this analysis.  
 
were present within the coding end sequence adjacent to the breakpoint. One junction 
contained 116 bp long insertion, part of which (59 nt) was dervied from chromosome 3.  In 
summary, our data demonstrate that translocations can arise in transformed Art-/- pre B cells 
and are further induced by IR. Moreover, these trans-rearrangements contain extensive 
deletions and complex junctional insertions.  
ATM deficiency abrogates partial rescue in T lymphocyte development and V(D)J 
rearrangements in irradiated Art-/- mice.  
Since ATM plays a key role in activating cellular responses to DNA damage, we 
hypothesized that IR-induced end joining in Artemis deficiency is triggered by ATM-dependent 
DNA damage response. To determine this, mice deficient in both Artemis and ATM were 
irradiated at 3 to 5 weeks of age with 2.5 Gy and analyzed 3 weeks later. Thymic cellularity was 
reduced in Art-/-Atm-/- mice as compared to the Art-/- mice by about 50% (Table 3.2). Next, 
thymocytes were examined for CD4, CD8 and TCRβ expression by flow cytometry. 
Representative plots of un-irradiated and irradiated Art-/-Atm-/- and Atm-/- thymocytes are 
shown in Figure 3.7A. As expected, the percentages of DP, sTCRβ+ and icTCRβ+ cells were 
markedly lower in Art-/-Atm-/- mice as compared to the WT and Atm-/- mice, and similar to those 
in the Art-/- mice (Figure 3.7B, Table 1). The Art-/-Atm-/- mice did not show a significant change in 
the number of DP and sTCRβ+ cells upon irradiation (Figure 3.7A, 3.7B). On comparison with the 
irradiated Art-/- mice, the Art-/-Atm-/- mice showed a significant reduction in the response to IR 
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as determined by DP and sTCRβ+ cells. However, we observed a small increase in the 
percentage of icTCRβ+ cells (2.6% + 0.3) in the Art-/-Atm-/-mice.  
 
Table 3.2: Impact of IR on T lymphocyte development in Art-/-Atm-/- mice 
 
 
0 4 124.6 + 24.9 83.4 + 1.03 19.4 + 1.3 28.8 + 2.8
2.5 4 100.3 + 25 74.3 + 2.02 18.2 + 1.7 22.5 + 1.2
0 5 6 + 2.6 0.06 + 0.02 1.5 + 0.2 0.4 + 0.1
2.5 6 8.4 + 2.7 52.7 + 5.2 5.3 + 0.7 12.3 + 4.2
0 6 0.8 + 0.1 0.4 + 0.1 0.7 + 0.3 0.4 + 0.1
2.5 8 0.8 + 0.1 0.7 + 0.6 1.5 + 0.6 2.6 + 0.3
0 6 100.1 + 21.8 86.6 + 1 2.2 + 0.4 14.5 + 0.01
2.5 4 90.1 + 50.6 70.7 + 5.2 4.1 + 0.6 31.5 + 5.1
sTCRβ+ cells                 
(% of total)
Thymocyte 















Figure 3.7:  ATM deficiency abrogates IR-induced T lymphocytes differentiation in Art-/- mice. 
 
(A) 3-5 weeks old Atm-/- and Art-/-Atm-/- mice were exposed to 2.5 Gy and analyzed 3 weeks 
later for lymphocyte development. (A) Flow cytometric analysis was done on thymocytes from 
the unirradiated and the irradiated mice for cell surface CD4, CD8, TCRβ and intracellular CD4 
and TCRβ expression. (B, C, D) Graphs representing percentage of thymocytes expressing (B) 
surface CD4 and CD8, (C) surface TCRβ and (D) intracellular TCRβ. The bars represent means for 




Next, to investigate the potential role of ATM in IR-induced V(D)J recombination, we 
examined Dβ1 to Jβ1rearrangements in the DNA isolated from the individual thymus by using 
PCR and Southern blot analysis (Figure 3.8, Top panel). We observed fewer PCR bands 
corresponding to rearrangements and increased intensity of the germline band in all the Art-/-
Atm-/- mice after IR as compared to the WT, Atm-/- and irradiated Art-/- mice (Figure 3.2). We 
sequenced these PCR products to analyze the breakpoint junctions and were able to isolate 
only 4 unique sequences from two mice. The only abnormality we observed was the presence 
of long P NT (7 and 8 bp long) in the two sequences from #1679 (Figure 3.8, Bottom panel).  
To determine if trans-rearrangements form in Art-/-Atm-/- thymocytes after irradiation 
PCR and Southern blot analysis was done for TCRγV to βJ trans-rearrangements. No trans-
rearrangement products were detectable in unirradiated (n=2) and irradiated Art-/-Atm-/- mice 
analyzed (n=5) (Figure 3.8A). These findings are in contrast to what we observed in Art-/- mice in 
which IR induced robust levels of transrearrangements (Figure 3.4). These results demonstrate 
that ATM deficiency substantially decreases IR-induced T lymphocyte development and Dβ1-to-
Jβ1 rearrangements in the Art-/- mice. Interestingly, low levels of rearrangements can be 
detected after IR in some Art-/-Atm-/- mice. In contrast, no aberrant trans-rearrangements were 
observed in these mice. Since thymic cellularity in Art-/-Atm-/- mice was reduced than in Art-/- 
mice, these cells might be particularly radiosensitive with reduced cell viability. Therefore, it is 
possible that low levels of rearrangements and lack of translocations may result from reduced 
number of precursors in the thymus.  
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Figure 3.8. (A) Thymic DNA was prepared from thymocytes isolated from the unirradiated and 
irradiated mice and PCR analyses done to determine Dβ1 to Jβ1 and aberrant TCRγV to TCRβJ 
rearrangements. A non-lymphoid tissue (tail) was included as a negative control. DNA input was 
normalized using PCR for a non-rearranging gene. (B) PCR products corresponding to Dβ1 to Jβ1 
rearrangements were subcloned into the TOPO2.1 vector and sequenced. Sequences from two 
irradiated Art-/-ATM-/- mice are shown. Dβ1 and Jβ1 coding end sequences are shown in boxes 
above the rearrangements. P NT are underlined. N NT are indicated between the coding 




V(D)J rearrangements and translocations induced in irradiated Art-/- pre-B cells are 
suppressed by ATM kinase inhibition.  
To confirm our above-mentioned findings in an immortalized system, the Art-/- pre-B 
cells were arrested in G1 and treated with a potent selective ATM kinase inhibitor, KU55933 
(Figure 3.9A) [273].  KU55933 did not reduce cell survival in the G1-arrested cells (Figure S3.3).  
The inhibition of ATM kinase activity significantly decreased the percentages of GFP+ cells in 
unirradiated and irradiated Art-/- cells in G1 (Figure 3.9B). Further, levels of coding joins at the 
pMX-INV and Igκ loci, analyzed by PCR and Southern blot analyses, were markedly reduced in 
cells that were treated with STI571, KU55933 and IR (Figure 3.9C).  
Next, we examined trans-rearrangements between the Igk and pMX-INV loci by PCR and 
Southern blot analysis (Figure 3.9D, left panel). We observed a decrease in frequency as well as 
levels of translocations after ATM kinase inhibition in the irradiated as well as unirradiated G1-
arrested cells (Figure 3.9D, right panel). Altogether, these findings demonstrate that inhibition 
of ATM kinase activity suppresses IR-induced rearrangements including translocations during 
V(D)J recombination in G1-arrested Art-/- pre B cells.  
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Figure 3.9:  ATM kinase inhibition in G1-arrested Art-/- pre-B lymphocytes suppresses normal 
and aberrant V(D)J rearrangements. 
 
(A) v-abl Art-/- pre-B lymphocytes were treated with STI571 and KU55933 simultaneously. 48 
hours later cells were irradiated with 5 Gy and analyzed 72 hours after IR. (B) Flow cytometry 
was done to determine the percentage of GFP+ cells 72 hours after IR. The bars represent 
means for each group with SEM. (C) DNA was collected and PCR analyses done to amplify the 
pMX-INV and IgLk coding joins. PCR products were confirmed by Southern blot analysis. DNA 
input was normalized using PCR for a non-rearranging locus. (D) Transrearrangements between 
pMX-INV and IgLk loci were amplified using PCR and confirmed by Southern blot analysis. DNA 
input was normalized using PCR for a non-rearranging gene. The table in the right panel shows 
the frequencies of trans-rearrangements. 
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3.4 Discussion  
The role of the ATM-dependent DNA damage response in inducing alternative end-
joining in the developing lymphocytes had not been fully characterized. Our studies reveal that 
upon irradiation in the absence of Artemis, RAG-induced breaks undergo robust V(D)J 
rearrangements, including chromosomal translocations. Using an inducible pre-B cell system, 
we show that this response is largely dependent on ATM-kinase activity. This study also 
demonstrates that chromosomal translocations can arise during the G1-phase of the cell cycle, 
independent of post-replication repair mechanisms and cell cycle checkpoints.  
IR-induced lymphocyte development and V(D)J recombination in Art-/- lymphocytes 
Low-dose IR partially rescued T lymphocyte development arrest in Art-/- mice. This 
rescue was associated with Dβ to Jβ rearrangements in nullizygous cells at levels comparable to 
those seen in the wild-type (WT) cells. Although TCRβ expression was also increased after IR in 
Art-/- mice, the levels were lower than those in the WT cells indicating that many of these 
rearrangements are not in-frame and are non-functional. Lack of peripheral single-positive T 
cells in irradiated Art-/- mice suggests that despite significantly increased intracellular TCRβ, the 
lymphocytes of these mice were not producing functional TCRs. This might indicate a 
requirement for a wave of IR-induced activity for subsequent rearrangements, as indicated by 
lower level of induction in Vβ to DJβ as compared to Dβ to Jβ rearrangements in Art-/- 
lymphocytes.  
IR failed to rescue B lymphocyte development in Art-/- mice, as was previously reported 
for DNA-PKcs mutant SCID mice (SCIDDNA-PKcs) [262]. p53 nullizygosity rescues only T cell, and 
not B cell, development in SCIDDNA-PKcs mice [274]. In contrast, Bcl2 overexpression, that inhibits 
cell death, promotes B cell development but has no effect on T cell development and 
differentiation in SCIDDNA-PKcs mice [275]. This suggests that differences in the regulation of 
checkpoints are responsible for selective B or T lymphocyte development. In our study, end 
joining was increased in irradiated v-abelson transformed Art-/- pre-B cells indicating that this is 
not a T cell-specific response and that IR is inducing similar DNA repair mechanisms in both cell 
lineages. Increased availability of RAG-generated DNA ends in Art-/- cells upon G1 arrest allows 
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repair by slow error-prone mechanisms, as is evidenced by the presence of low levels of coding 
joins in these cells. However, an increase in coding join formation after IR suggests a role for IR-
induced DNA damage response in mediating end joining.  
Elevated levels of genomic instability in Art-/- lymphocytes after low-dose IR 
Increased interchromosomal trans-rearrangements in Art-/- lymphocytes after IR, 
particularly between TCRγ and TCRβ loci, suggests that the DNA-damage induced end joining is 
translocation-prone. Human TCRγ and TCRβ loci are both located on chromosome 7, and 
aberrant end-joining can lead to deletions or inversions [271]. Inversions between IgVH and 
TCRJα segments, located on chromosome 14, have been observed in some B cell leukemia 
[276]. We also observed complex breakpoint junctions within these translocations. One such 
translocation junction from Art-/- c.4 cells contained a 59 bp long sequence from chromosome 
3. This might have resulted from joining of IR-damaged DNA with the coding ends through 
unclear mechanisms, as there were no obvious microhomologies within that junction. Trans-
rearrangements are frequently observed in cells with ATM, NBS1 or MRE11 mutations [170, 
220, 221]. Loss of DNA ends indicated by hybrid join formation in these cells (Figure 1.6), has 
suggested that these proteins play roles in maintaining DNA end complex stability [128, 166]. 
We have also recently shown increased frequency of trans-rearrangements and deletional 
hybrid joins in lymphocytes harboring a hypomorphic Artemis mutation (Chapter 2) [82]. We, 
however, did not detect hybrid joins (data not shown) in Art-/- lymphocytes after irradiation 
despite the presence of robust hairpin opening and end-joining activities. This suggests that 
other processes involving complex and erroneous end processing and decreased bias towards 
intrachromosomal joining might be promoting aberrant repair after irradiation in the absence 
of Artemis.  
IR-induced V(D)J rearrangements in Art-/- lymphocytes are dependent on ATM kinase activity.  
ATM localizes to RAG-induced breaks and plays an important role in maintaining 
genomic stability during antigen receptor assembly [125, 129]. ATM deficiency alone does not 
markedly impair V(D)J recombination. During V(D)J recombination ATM has functional 
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redundancies with DNA-PKcs for efficient signal join formation [277, 278]. Combined XLF and 
ATM deficiency results in severe block in lymphocyte development [275]. ATM also regulates 
transcription in developing lymphocytes following RAG-induced breaks or genotoxic DSBs [279]. 
ATM-deficient cells exhibit increased coding end accumulation and loss of chromosomal 
integrity at the antigen receptor loci [125, 128]. This suggests that ATM is not essential for 
coding join formation but plays important role as a tumor suppressor during V(D)J 
recombination by preventing genomic instability.  
In this study, we have delineated the role of ATM-dependent DNA damage response in 
inducing chromosomal transrearrangements in C-NHEJ-deficient developing lymphocytes. We 
observed marked reductions in normal and aberrant V(D)J rearrangements and in T lymphocyte 
development in Art-/-Atm-/- mice after IR compared to that seen in Art-/- mice post-IR. Hence, 
ATM is required to mediate the IR-induced events observed with Artemis deficeincy. It is 
possible that Art-/-Atm -/- lymphocytes undergo DNA-PKcs-mediated apoptosis due to 
accumulation of DNA breaks and IR hypersensitivity. DNA-PKcs phosphorylates p53 in ATM-
deficient but not wild-type lymphocytes after IR which triggers apoptosis [280].  However, we 
demonstrated that ATM kinase inhibition in immortalized Art-/- pre-B cells does not affect 
survival of G1-arrested cells after IR and yet replicates our findings in irradiated Art-/-Atm-/- 
mice. Using inducible pre-B cells also allowed us to examine the role of ATM kinase activity 
specifically in G1, independent of its role in cell cycle checkpoint activation. Lack of DNA end 
complex stability, in the absence of either ATM or ATM kinase activity, may at least partially 
account for the decreased intralocus V(D)J rearrangement in Art-/-Atm-/- primary T lymphocytes 
and Art-/- pre-B cells treated with ATM kinase inhibitor. However, we reason that loss of this 
function should also predispose to more translocations due to aberrant repair of prematurely 
released ends in the absence of C-NHEJ upon irradiation. Because IR failed to induce 
translocations in Art-/-Atm-/- lymphocytes, the ATM-dependent damage response must have 
additional roles beyond maintaining DNA end complex stability. 
Mechanisms of ATM kinase-dependent end-joining induced by IR in the absence of Artemis.  
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Formation of coding joins in the absence of Artemis requires another nuclease to open 
the hairpins prior to end-joining. Low level alternative nuclease(s) activity is indicated by the 
presence of some coding joins in Art-/- lymphocytes. I have shown that alternative nuclease 
activity is highly inducible by low-dose IR, is associated with extensive resection and is linked to 
addition of long stretches of P-nucleotides at the junctions. The IR-induced response can rarely 
lead to aberrant end-joining in the wild-type cells involving longer resection of the coding ends. 
However, end-joining induced by IR in the absence of Artemis is associated with increased 
junctional complexity that is not observed in unirradiated Art-/- cells or in irradiated WT cells. 
This suggests that distinct factors might be involved in mediating aberrant end-joining after IR 
in the absence of Artemis. 
MRE11 and CtIP are involved in DNA end resection during homologous recombination 
and have been implicated in error-prone alternative end-joining [121, 124, 126]. MRE11 has 3’ 
to 5’ exonuclease activity and can also open hairpin loops in vitro [123]. CtIP interacts with 
MRE11 for double-strand break resection during homologous recombination [121]. CtIP also 
promotes end resection of RAG-generated breaks via MMEJ in the absence of H2AX and this 
resection is dependent on ATM kinase [126]. This nucleolytic activity is associated with 
extensive resections, and probably does not play a prominent role during normal V(D)J 
recombination [121]. The MRN complex and CtIP are both phosphorylated by ATM during the 
DNA damage response [72]. Therefore, MRE11 and CtIP are strong candidates in mediating 
alternative end joining in Artemis-deficient lymphocytes and investigating the roles of MRE11-
CtIP in IR-induced end-joining will further improve our understanding of alternative end-joining. 
Qualitative analysis of breakpoint junctions including  those from transrearrangements 
isolated from irradiated Art-/- cells revealed complex junctions. Templated nucleotide insertions 
from regions close to the breakpoints suggest a role for IR-induced, error-prone, template-
dependent polymerases. Similar complex template nucleotide insertions have been observed at 
translocation junctions in follicular and mantle cell lymphomas [281]. DNA polymerase theta 
(PolQ), which is expressed in testicular and lymphoid tissue and overexpressed in colon, 
stomach and lung cancers, has been shown to lead to such complex partially-templated 
90 
 
insertions in Drosophila [281, 282]. Interestingly, combined ATM and PolQ deficiency in mice 
results in reduced viability and delayed thymic lymphoma onset suggesting a role for PolQ in 
DNA DSB repair [283, 284]. The function of mammalian PolQ needs to be further characterized, 
especially during aberrant V(D)J recombination. Gap-filling synthesis by DNA polymerases with 
established roles during V(D)J recombination, such as Polµ/λ, is also susceptible to template 
slippage resulting in direct repeats and frameshift synthesis [285, 286]. These polymerases are 
actively involved in DNA repair by NHEJ.  We suggest that IR-induced endonuclease activity 
leads to extensive DNA end resection and that DNA polymerases perform error-prone gap-
filling synthesis to prevent extreme resection and promote end-joining. These polymerases 
might also generate synthesis-dependent microhomologies. In this scenario, the junctional 
modifications are the result of combined processing of the ends by nucleases and polymerases. 
Further characterizing the roles of these factors in V(D)J recombination will improve our 
understanding of DNA end processing and the contributions of error-prone nucleases and 
polymerases to aberrant end-joining. 
We did not observe markedly increased use of microhomologies at the joins from the 
irradiated Art-/- lymphocytes. This might be due to our small sample size. Alternatively, it might 
suggest that once the hairpins are opened, at least some of them are joined by DNA 
LigIV/XRCC4. Malu et al. recently identified Artemis C-terminal regions critical for direct 
interaction with LigIV and for coding join formation in plasmid substrates [76]. In the absence of 
this interaction, the coding joins were not qualitatively different from wild-type joins. This 
suggests that even in the absence of Artemis-LigIV interaction, the DNA ends can be joined by 
LigIV/XRCC4. This might be mediated through interactions of LigIV with factors upstream of 
Artemis such as RAG and/or DNA-PK. Irradiation of SCIDDNA-PKcs mice induced rearrangements at 
TCRγ, β and δ loci. These joins contained smaller-sized and less frequent P-nucleotides than 
junctions from unirradiated cells [262, 266]. The differences we observed might be due to the 
presence of intact downstream C-NHEJ factors which may be recruited and activated by the 
Ku/truncated DNA-PKcs complex and perhaps other proteins including ATM after induction of 
DNA damage response [159]. Thus, the specific nature of C-NHEJ defect might play an 
important role in determining the factors involved in end-processing and joining. 
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Our studies show that ATM kinase-dependent DNA damage response induces pathways 
that are translocation-prone, particularly in cells with compromised C-NHEJ. This function is 
distinct from its role in preventing genomic instability in the absence of DNA damage response. 
Based on our findings, we propose that IR induces an increase in ATM activation at RAG-
induced breaks by either increased phosphorylation of ATM already present at the DNA ends or 
increased ATM recruitment to the ends. In case of intact C-NHEJ, DNA damage response rarely 
leads to aberrant end-processing and interlocus end-joining of RAG-generated breaks. These 
rare events may result from erroneous resolution of a few DNA ends that persist and are 
accessible to error-prone pathways induced by IR. In case of Artemis deficiency, we propose 
two non-mutually-exclusive mechanisms by which the hairpin ends are processed and joined 
after IR (Figure 4.2). In the first model, in the absence of Artemis, alternative nuclease(s) are 
readily activated by ATM-dependent damage response to open the hairpin coding ends. The 
ends can then be joined by C-NHEJ ligation complex comprising of XRCC4 and Ligase IV. The 
alternative nuclease(s) activity is responsible for increased aberrant end-processing and 
chromosomal translocations. In the second model, the ATM-dependent IR-induced response 
triggers a distinct error-prone pathway consisting of a nuclease, polymerases and a ligation 
complex that will process and join ends in the absence of Artemis. MRE11/CtIP-mediated 
nuclease activity and ligation complex formed by Ligase III/XRCC1 or even Ligase I are potential 
candidates for this error-prone end-processing and joining.  Studies examining combined 
deficiencies of Artemis with other factors would help dissect these pathways. MRE11 inhibition, 
CtIP knockdown in Art-/- pre-B cells will help us examine the role of this nuclease activity in 
mediating end-joining after IR. Using DNA LigIV inhibitor in this pre-B cell system will allow us to 
determine the differences in junctional structures and thus contribution of intact downstream 
C-NHEJ ligation complex to end-joining in Art-/- cells after IR.   
ATM-independent end-joining:  
The presence of low levels of coding joins in the context of combined Artemis- and ATM-
deficiencies after IR indicates that IR-induced ATM-independent mechanisms also contribute to 
end-joining. This end-joining might proceed in an MRN-dependent manner or through DNA-
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PKcs. The latter has redundant functions with ATM; it is capable of phosphorylating many DDR 
proteins, including H2AX [280]. Additionally, RAG-mediated endonuclease activity can catalyze 
hairpin opening in vitro [21]. Two out of four unique sequences isolated from Art-/-Atm-/- 
irradiated mice contained 7-8 bp long P-nucleotides at both coding ends within each junction, a 
feature unique to these junctions. This is suggestive of RAG-mediated hairpin opening as RAG 
can nick the hairpin substrates as much as 10 bp away from the apex in vitro [21].  
In summary, our study suggests a role for ATM-dependent DNA damage response in 
translocation formation in Artemis-deficient lymphocytes during V(D)J recombination. Radio- or 
chemotherapy, such as topoisomerase inhibitors, that induce DSBs can induce ATM-mediated 
responses. This may lead to oncogenic events that may manifest later in life as therapy-
mediated tumors. Concurrent inhibition of ATM kinase or othefactors that constitute A-EJ 
pathway may help reduce the risk of such oncogenic events.  
3.5 Materials and Methods 
Mice. WT, Art-/-, Atm-/- and Art-/-Atm-/- were on mixed 129Svev/C57Bl6 background. Mice were 
housed in a specific pathogen-free facility for immunodeficient animals. All the protocols were 
approved by University Committee on Use and Care of Animals  (UCUCA) at the University of 
Michigan.  
Irradiation and flow analysis of lymphoid tissues.  Mice were irradiated at 3 to 5-weeks of age 
with a single dose of 2.5 Gy using 137-Cs source. 3 weeks later, they were analyzed. Bone 
marrow, thymus, spleen and lymph nodes were collected. Single cell suspensions were 
prepared and analyzed by flow cytometry using CD4, CD8, TCRβ antibodies for T lymphocytes 
and B220, IgM and CD3 antibodies for B lymphocytes. Thymocytes were also permeabilized and 
fixed using 4% paraformaldehyde and 0.1% saponin and stained for TCRβ and CD4. Flow 
analysis was done on BD Accuri C6 flowcytometer. Data was analyzed in Flowjo. 
PCR analysis for TCR rearrangements. PCRs for intralocus V(D)J rearrangements were 
performed as described previously [82]. Transrearrangement PCRs were performed as 
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described by Jacobs et al. [287]. PCR analyses were done on all the irradiated Art-/- and Art-/-
ATM-/- mice.  
Culture of v-abl pre-B lymphocytes. V-abl pre-B cells were cultured in DMEM supplemented 
with 10%FBS, HEPES, NEA, glutamine,penicillamine, β-ME. For G1 arrest, 107 cells were treated 
with 3µM STI571. Cells were irradiated 48 hours later at 1, 2.5 or 5 Gy. For cycling cells, 107 cells 
were plated just before irradiation. For ATM-kinase inhibition experiments, 15µM KU55933 was 
added to cells at the time of STI571 treatment or an hour before irradiation. Cells not receiving 
KU55933 were treated with 15µl of DMSO. Cells were irradiated using 137-Cs source. Cells were 
analyzed by BD Accuri C6 flow cytometer. To express full-length Artemis in pre-B cell lines, 
Artemis cDNA was cloned into an MSCV retroviral vector containing an IRES-dsRed sequence. 
Retrovirus was produced in HEK293T cells and viral supernatant was used to transduce an 
Artemis null pre-B cell line. dsRed positivity was used as a marker for transduced cells. 
Transduced cells were then sorted to generate single cell clones expressing wildtype Artemis. 
PCR analysis for Igκ and pMX-INV rearrangements. Igκ and pMX-INV coding join PCRs were 
performed as described previously [128]. For PCR analysis of Igκ to pMX-INV trans-
rearrangements, primers flanking Vκ6-23 and IRES sequences were used. We used primers 
(15pM per reaction) that were used for coding join analysis [128]. 0.1µg of DNA was amplified 
using the following PCR conditions: 25 cycles of 94°C, 60°C and 72°C for 30 seconds each using 
JMS 528 and JMS579. This was followed by 25 cycles of the same PCR conditions using pB and 
pκ6d primers. The PCR products were run on 1.5% agarose gel and transferred to Zetaprobe 
membranes to be analyzed by Southern blot. The membranes were probed with radiolabeled 
probes. PCR analyses were done on samples collected in at least three independent 
experiments. Samples from two independent experiments were repeated at least twice.  
Sequencing analsysis. PCR products were subcloned using pCR Topo2.1 and sequenced. 
Sequences were analyzed using SeqMan Pro software, and online NCBI Blast and IMGT 
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3 to 5-weeks-old WT mice were exposed to 2.5 Gy and analyzed 3 weeks later for lymphocyte 
development. (A) Flow cytometric analysis was done on thymocytes from the unirradiated and 








PCR products for Dβ1 to Jβ1 rearrangements were subcloned into the TOPO2.1 vector and 
sequenced. Analysis of sequences from two irradiated Artemis-null mice is shown. (A) Pie 
charts showing the percentages of sequences with deletions of 0 bp, 1-10 bp and >10 bp, 
insertions of 0 bp, 1-10 bp and >10 bp, P NT of 0 bp, 1-3 bp and >3 bp and MH of 0 bp, 1-4 bp 
and > 4bp. (B) Blast analysis was done to map the sequences inserted (query) at the breakpoint 
junction to the mouse TCRb locus (subject). The lines indicate the matched sequences.  
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Figure S3.3. Survival of pre-B cells after IR 
 
107 cells were plated per sample and cells were counted again at the time of harvest. The ratio 




Figure S3.4: Dβ1-to-Jβ1 and Vγ-Jβ Sequences 
 
 
Coding end sequences are shown in boxes above the rearrangements. P NT are underlined. N 
NT are indicated between the coding segments. MH are represented in bold. Sequences 
derived from the adjacent sequences are highlighted. Sequences for the unirradiated mice were 








Figure S3.5: Coding join sequences (WT INV5) 
 
Coding end sequences are shown in boxes above the rearrangements. P NT are underlined. N 
NT are indicated between the coding segments. MH are represented in bold.  
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Figure S3.6: Igκ coding join sequences (Art-/- c.30) 
 
Coding end sequences are shown in boxes above the rearrangements. P NT are underlined. N 
NT are indicated between the coding segments. MH are represented in bold. The sequences 
were aligned in Seqman Pro. The mismatched sequences near the breakpoint junctions are 
shown in red. 
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Figure S3.7: pMX-INV coding join sequences (Art-/- c.30) 
 
Coding end sequences are shown in boxes above the rearrangements. P NT are underlined. N 
NT are indicated between the coding segments. MH are represented in bold. The mismatched 
sequences near the breakpoint junctions are shown in red. 
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Figure S3.8: Igκ coding joins sequences (Art-/- c.4) 
 
Coding end sequences are shown in boxes above the rearrangements. P NT are underlined. N 




Figure S3.9: pMX-INV coding join sequences (Art-/- c.4) 
 
Coding end sequences are shown in boxes above the rearrangements. P NT are underlined. N 
NT are indicated between the coding segments. MH are represented in bold. The sequences 





Conclusions and Future Directions 
 
4.1 Overview 
 The process of V(D)J recombination, although essential for adaptive immunity and 
antigen receptor diversity, poses a risk to chromosomal integrity. Integration of processes, such 
as germline transcription, chromatin modification, RAG-mediated cleavage, DNA end-complex 
stability, end-processing and joining, DNA damage response and cell death activation in case 
ends are not repaired, is vital to preventing genomic instability.   Over the last two decades, 
pathways and factors that have tumor suppressor function or oncogenic potential during V(D)J 
recombination have been identified. However, interactions between these factors and 
contributions of different end-joining mechanisms are still not fully characterized due to 
functional redundancies. I investigated the mechanisms that underlie spontaneously arising or 
ionizing-radiation induced structural chromosomal aberrations during V(D)J recombination.  In 
the following chapter, I will first summarize my conclusions about the potential mechanisms of 
aberrant end-joining of RAG-induced breaks in different mutant backgrounds. I will also discuss 
potential future studies that will help further understand these processes. The second part of 
this chapter addresses the implications of these findings for tumor development in patients and 
potential interventions.  
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4.2 Mechanisms of Genomic Instability Associated with Defective V(D)J Recombination 
 My studies have offered useful insight into the mechanisms that lead to spontaneous 
genomic instability in non-malignant cells from mice with hypomorphic RAG1 and Artemis gene 
mutations [82, 200]. These mutations are associated with increased frequency of mis-repair of 
the coding ends resulting in aberrant interchromosomal transrearrangement. Indeed, these 
mice develop lymphoid tumors on a p53-null background. These studies provide the first in vivo 
evidence for potential functions of RAG1 and Artemis proteins in maintaining post-cleavage 
complex (PCC) stability during V(D)J recombination. Additionally, I have also demonstrated that 
ATM kinase-mediated DNA damage response can facilitate robust error-prone alternative end-
joining in Artemis-deficient lymphocytes.  
Does Artemis have a role in maintenance of postcleavage complex (PCC) stability? 
What constitutes a postcleavage complex? 
Biochemical studies examining pre- and post-cleavage complex assembly during V(D)J 
recombination have mainly examined the interaction of RAG proteins with DNA ends. After 
cleavage, the newly generated DNA ends are maintained in a complex comprising of RAG 
proteins. The association of hairpins in the PCC is labile in vitro with majority of the hairpins 
dissociating from the complex [181]. How C-NHEJ factor access the cleaved ends remains 
elusive. Contribution of C-NHEJ factors to PCC stability has also not been directly examined. 
Two models can be used to explain how C-NHEJ factors gain access to DNA ends. In one model, 
Ku70/80 heterdimer, DNA-PKcs and subsequently Artemis, access DNA ends held by RAG 
proteins within the PCC complex. Thus, DNA ends will be associated with proteins throughout 
the process of recombination. Alternatively, coding ends are released from the complex and 
then readily recognized by Ku proteins. In this model coding ends will be transiently free 
between release from the PCC and binding by C-NHEJ factors and potentially accessible to error 
prone end joining pathways. Both Ku and DNA-Pkcs have been suggested to bridge DNA ends in 
vitro [288]. Ku70/80 also directly interacts with RAG1. Therefore, it is highly likely that Ku70/80 
are recruited to the DNA ends by RAG and then RAG, DNA-PK and other factors localizing to the 
DNA ends form a scaffolding complex that retains DNA ends at cleavage-joining interphase.  
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How may Artemis contribute to PCC stability? 
 The contribution of Artemis to PCC stability has not been explored before our studies in 
Art-P70 mice. The increased frequency of trans-rearrangements and deletional hybrid joins in 
Art-P70 but not Art-/- murine lymphocytes indicates the significance of Artemis C terminus in 
preventing genomic instability. Based on our findings, it is reasonable to infer that Artemis plays 
important role in DNA end complex stability via its C-terminus. This function is distinct from its 
role in hairpin opening during normal V(D)J recombination. ATM, MRE11 and NBS1 have been 
previously suggested to have a role in stabilizing the DNA ends after cleavage [128, 166]. These 
proteins do not appear to play essential roles in normal V(D)J recombination. However, their 
deficiency is associated with an increase in aberrant rearrangements of the RAG-induced breaks 
suggesting that they are important in preventing aberrant V(D)J recombination and genomic 
instability.  Based on these findings, I propose a model in which ATM, MRN complex (MRE11, 
RAD50, NBS1) and Artemis, via its C-terminus, may act in the same pathway of DNA end-
tethering during antigen receptor assembly (Figure 4.1). ATM most likely mediates this effect by 
phosphorylating the MRN complex, Artemis C-terminus and H2AX. Phosphorylated H2AX 
(γH2AX), in turn, protects the RAG-induced ends from excessive resection by regulating the 
access of certain DNA damage response factors [126]. The MRN complex may have direct roles 
in retention of the ends within the complex. Artemis C-terminus may induce conformational 
changes within the PCC either directly or through interaction with other factors such as MRN 
complex that are important to retain DNA ends. Loss of Artemis C-terminus would interfere 






Figure 4.1: Model of Postcleavage Complex Instability in Art-P70 Mutant Lymphocytes 
 
 
Figure 4.1. At the RAG-induced breaks, ATM phosphorylates Artemis C-terminus, H2AX and the 
MRN complex. Artemis and MRN play key roles in tethering the DNA ends together in the 
postcleavage complexes. Loss of Artemis C-terminus results in loss of ATM phosphorylation 
sites which may induces conformational changes within the complex resulting in premature 
release of ends and aberrant rearrangements.  
 
Future studies. 
The precise spatiotemporal mechanisms that govern DNA end stabilization within the PCC by 
various proteins are still undefined. Determining the composition of the PCC and protein-DNA 
contacts within this complex is necessary to understand how DNA ends are transferred from 
RAG complex to C-NHEJ factors. Characterization of discrete PCC in the presence of not only 
RAG but other proteins of interest in vitro using physiologically relevant substrates,  
108 
 
electrophoretic mobility shift assays (EMSA) and in-gel DNA footprinting assays will provide 
important information about the contribution of C-NHEJ factors to DNA end retention. These 
biochemical assays can also be used to examine the interactions of Art-P70 and other mutant 
proteins with RAG-generated ends.  
 Technical difficulties in examining the direct interaction of these proteins with each 
other and with the DNA ends within an end-complex have posed challenges to understanding 
these processes. Recently, Wang et al. used fluorescence resonance energy transfer (FRET) to 
examine RAG-mediated cleavage reaction and PCC stability with core RAG proteins and a RAG2 
mutant that had been suggested to destabilize the complex [289]. This sensitive system could 
also be used for continuous and real-time monitoring of the kinetics of PCC formation and 
retention or release of coding ends from complexes in the presence of RAG, C-NHEJ factors and 
defective proteins such as Artemis-P70 and RAG1-S723C.  
To understand the role of the Artemis-C terminus in stabilizing DNA ends, it is critical to 
define regions that might be involved in this process. Expressing deletion constructs in Artemis-
deficient lymphocytes followed by site-directed mutagenesis can be useful in identifying these 
critical regions. 
Malu et al. recently identified three critical regions in the Artemis C-terminus for direct 
interaction with DNA Ligase IV (LigIV) that are important for coding join formation in plasmid 
substrates and are missing in Art-P70 [76]. Though the levels of coding joins were low after 
ablation of this interaction through site-directed mutagenesis, the coding junctions formed 
were not qualitatively different from those recovered from wild-type cells. We also did not 
observe an increase in frequency of joins with aberrant sequences in Art-P70 mutant 
lymphocytes [82]. These two studies suggest that even in the absence of Artemis-LigIV 
interaction, the DNA ends can be joined by LigIV/XRCC4 complex. This might be mediated 
through interactions of LigIV with factors upstream of Artemis such as RAG and/or DNA-PK 
complexes. It would be interesting to determine the in vivo effect of loss of Artemis-LigIV 
interaction on aberrant V(D)J recombination and define the significance of this interaction in 
terms of PCC stability and DNA repair pathway choice. Expression of mutant proteins defective 
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in this interaction in v-abl pre-B cell system or a knock-in mouse model will help understand the 
significance of these interactions.  
How does RAG1-S723C contribute to genomic instability? 
RAG proteins have been shown to function directly in complex assembly and stability 
through their interactions with the DNA ends and/or with chromatin. For RAG1-S723C 
mutation, we have proposed two mechanisms which are not mutually exclusive: pre-cleavage 
substrate recognition errors and postcleavage end complex instability. Characterizing their 
individual contribution will help us understand the precise mechanism of genomic instability in 
RAG1-S723C mice. Chromatin immunoprecipitation (ChIP) assays could be used to determine 
localization of RAG1-S723C/RAG2 to genomic regions that are not within antigen receptor loci.  
We also examined the effect of general DNA damage induction on V(D)J recombination 
in these mice.  Although irradiation failed to induce development or intralocus V(D)J 
rearrangements in RAG-S723C lymphocytes (Figure S4.1), whether irradiation induced 
interchromosomal trans-rearrangements was not examined. It would be interesting to 
determine if coding ends are processed differently after DNA damage response induction in 
RAG1-S723C lymphocytes. 
How is DNA repair pathway choice determined?  
The presence of truncated Artemis protein that retains endonucleolytic activity may 
block the access of other nucleases to DNA ends. Thus, the composition of proteins in the PCC 
may be an important determinant of DNA repair pathway choice. Consistent with this idea, 
abrogation of RAG1 or RAG2 protein-protein interactions results in premature release of coding 
ends from PCC with joins suggestive of alternative end-joining (A-EJ) [65, 181, 185]. Mutations 
that make the complexes extremely unstable during early V(D)J recombination may be 
associated with end-joining by alternative pathways. Alternatively, this may result from loss of 
regions critical for interaction with C-NHEJ factors thus making the ends available for A-EJ. A 
frameshift RAG2 mutant that predisposes to error-prone end-joining was once thought to be 
dysfunctional in post-cleavage complex-coding end stabilization [185]. Recently, it was shown 
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that an unstable coding end complex might not be responsible for this end-joining defect [289]. 
Thus, other factors that link RAG1/2-mediated cleavage and repair by NHEJ may contribute to 
defective end-joining and need to be investigated. Interestingly, we observed that RAG1-S723C 
mutation, also associated with premature release of DNA ends, was associated with coding 
joins that are qualitatively similar to WT joins [200]. The difference in repair pathway selection 
might result from retention of the regions in the RAG1-S723C/RAG2 complex important for 
interactions with C-NHEJ factors. Structure-function and biochemical studies to identify specific 
functions within certain regions and defining critical residues within these proteins are thus 
critical to our understanding of the full functional spectrum of these proteins.  
Is IR-induced end-joining observed in the absence of Artemis mediated by a distinct pathway 
or merely by nuclease substitution? 
Currently, there is no consensus on the molecular components of alternative end-joining 
pathway (A-EJ). It is also not clear if A-EJ is one distinct pathway or several different pathways 
which may or may not have functional redundancies with C-NHEJ factors. A distinct pathway 
would require at least one nuclease, a polymerase and a ligase. Alternatively, a certain non-C-
NHEJ factor may substitute for a missing C-NHEJ factor. Based on my findings, I propose that in 
the absence of Artemis, another nuclease opens the hairpin coding ends with slow kinetics. This 
nucleolytic activity may be enhanced after IR. Alternatively, a distinct nucleolytic activity might 
be induced by IR. The ends could then be joined by LigIV/XRCC4 and/or other ligation 
complexes. On the other hand, a completely distinct end-joining pathway comprising of 
completely different nucleases, polymerases and ligation complex may be induced after IR. 









Figure 4.2: Potential Mechanisms of IR-Induced V(D)Recombination in the Absence of Artemis 
 
Figure 4.2. In the wild-type lymphocytes, V(D)J recombination proceeds normally in the 
presence of Artemis (1). In the Artemis-deficient lymphocytes, hairpin coding ends accumulate 
(2). After general DNA damage response (DDR) induction, ATM is activated and mediates end-
joining through some as-yet undetermined mechanisms (3). This may involve MRE11- and CtIP-
promoted hairpin opening (4). Extensive resection occurs at the ends (5). The ends could then 
be ligated by either XRCC4/LigIV complex (5), or by XRCC1/LigIII/LigI - the activities of which are 
associated with increased translocation frequency (6). 
 
How is IR-induced end-joining different in DNA-PKcs and Artemis-mutant mice? 
Irradiation of DNA-PKcs defective mice and pre-B cells also induces V(D)J recombination [262, 
266]. However, IR-induced joins were qualitatively different from those we observed in 
irradiated Art-/- murine lymphocytes. Binnie et al. observed fewer P-nucleotide insertions after 
IR in DNA-PKcs-mutant mice [266]. In contrast, we observed an increase in the frequency and 
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length of P-nucleotide insertions at the breakpoint junctions from the irradiated Art-/- 
lymphocytes. The difference in our findings might be due to the use of extrachromosomal 
plasmid substrates by Binnie et al., whereas we examined V(D)J recombination at the 
endogenous and chromosomally integrated loci. Alternatively, the temporal sequence of events 
may also determine how the ends are processed. After IR, ATM might phosphorylate Artemis in 
DNA-PKcs-deficient cells, and the intact downstream C-NHEJ factors might still be able to 
process and join the ends in a wild-type manner. In contrast, in the absence of Artemis, another 
nuclease would have to be recruited in order to open coding ends after irradiation. This 
nuclease may be prone to adding long stretches of P-nucleotides by nicking several nucleotides 
away from the apex of the hairpins. In addition, ends processed with slow kinetics may also be 
available to a completely distinct A-EJ pathway.  
What factors are involved in IR-induced end joining? Several factors have been 
implicated but none have been established as definitive A-EJ factors. MRE11- and CtIP- 
mediated resection has been suggested to be involved in microhomology-mediated end joining 
(MMEJ) as discussed in sections 1.8 and 3.4.  The role of error-prone polymerases in this 
process also needs to be delineated. Polymerase recruitment is locus-specific, and polymerase 
expression often varies by lymphocyte developmental stage [19, 20]. TdT and DNA polymerase 
µ have been shown to be recruited by Ku and DNA-PKcs in vitro [290-292]. Thus, it is not 
surprising that, in Ku- or DNA-PKcs-deficient cells, there is a paucity of N-nucleotides [161, 293, 
294]. However, N-NT are not absent in Art-/- cells, and after IR, nucleotide insertions are 
increased. This might result from IR-induced polymerase activity at breakpoint junctions lacking 
Artemis. Gap-filling synthesis by DNA polymerases (Polµ/λ) prevents extensive deletions, but 
these polymerases are error prone and susceptible to template slippage and frameshift 
synthesis [285]. Template slippage would result in direct repeats. The character of joins in 
Artemis-deficient mice after IR is suggestive of error-prone gap filling. A detailed analysis of the 
complex roles of these polymerases in IR-induced V(D)J recombination would improve our 
understanding of breakpoint processing. A potential role of different ligase/XRCC complexes 




To identify the molecular components of the poorly characterized A-EJ pathway during 
V(D)J recombination, combined deficiencies can be utilized. Inhibiting or knocking down 
potential candidates such as MRE11/CtIP in our Art-/- pre-B cells would allow us to examine the 
roles of these factors in A-EJ. 
Ochi et al. recently used structural analysis to describe Artemis-LigIV interaction and 
predicted that a similar interaction between Artemis and DNA Ligase I is possible. DNA Ligase I 
is a potential A-EJ factor. Similar protein interactions may exist to recruit other proteins when a 
C-NHEJ factor is missing. Using a LigIV inhibitor in v-abl Art-/- pre-B cells to determine join 
qualitative and quantitative differences would thus be interesting [295]. Combined Artemis and 
LigIII deficiencies can also provide useful information about the role of ligases during IR-induced 
end-joining. 
4.3 Implications for Tumor Development in Patients 
These studies have important prognostic implications for patients. Undiagnosed 
hypomorphic mutations that lead to mild immunodeficiency symptoms may increase 
predisposition to tumorigenesis later in life. Also, patients receiving bone marrow transplants 
might still be at risk of developing tumors.  
My studies that examine IR-induced activation of translocation-promoting alternative 
end-joining suggest a mechanism by which systemic DSB-inducing radio- and chemo-therapy 
might cause aberrant chromosomal rearrangements. This may result in drug resistance, relapse 
of tumors which are genetically distinct from the primary tumor or development of therapy-
induced tumors in other tissues. Type II topoisomerase poisons that stabilize DNA DSBs are 
frequently used to treat cancers [296]. Their use is associated with high incidence of therapy-
related secondary leukemia harboring 11q23 translocations involving the MLL gene. Combined 
chemo- and radiotherapy for solid tumors is also rarely associated with acute leukemia with 
chromosomal aberrations that may involve duplications and translocations including BCR/ABL1 
rearrangement [297].   
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Understanding these mechanisms will help us define the etiology of therapy-related 
tumors as well as develop novel therapeutic interventions. Concomitant inhibition of DNA 
damage response has been suggested to sensitize tumors. I suggest that this will have the 
added benefit of preventing future oncogenic events. Developing ATM-inhibitors for clinical use 



















Figure S4.1: Low dose ionizing radiation induces apoptosis in RAG1-S723C lymphocytes and 




(A)RAG1-null and RAG1-S723C mice were irradiated at 3-5 weeks of age at 250 cGy. Three 
weeks later they were analyzed for lymphocyte development (top panel) and V(D)J 
rearrangements (bottom panel). (B) Mice were irradiated at 250 cGy and analyzed 24, 48 and 
72 hours later for apoptosis. Apoptosis was determined by Annexin V positive population in 
double negative (DN) T lymphocytes that were negative for 7-AAD (left panel). Graphs 
representing Annexin V+ cells with bars indicating means and standard error of means are 
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